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Introduction {#sec001}
============

Natural products with anticancer activities have gained increased attention due to their favorable safety and efficacy profiles as possible therapeutic agents that are not toxic to the surrounding healthy tissue. Of special interest is to determine how these novel compounds affect the endoplasmic reticulum (ER), an essential organelle for proper protein folding. Different physiological and pathological conditions can perturb protein folding in the ER, leading to a condition known as ER stress. ER stress activates the unfolded protein response (UPR), a complex intracellular signal transduction pathway that reestablishes ER homeostasis through adaptive mechanisms involving the stimulation of autophagy. The goal of the UPR is to restore optimal ER function. However, when persistent, ER stress can switch from the cytoprotective functions of UPR and autophagy to promote cell death mechanisms \[[@pone.0164115.ref001]\].

Flavonoids from naturally rich fruits modulate cell cycles, induce apoptosis, and inhibit extracellular regulated kinase (ERK) phosphorylation; mechanism that are linked to their confirmed anti-carcinogenic, anti-proliferative, co-chemotherapeutic, and estrogenic effects \[[@pone.0164115.ref002]\]. Numerous reports support the fact that many natural products play a positive role in cancer prevention and treatment by adjusting the oxidative stress response, inhibiting cancer cell proliferation and modulating apoptosis and autophagy; mechanisms that control cellular fate by regulating the turnover of organelles and proteins \[[@pone.0164115.ref003],[@pone.0164115.ref004]\]. In general, autophagy blocks the induction of apoptosis, while apoptosis-associated caspase activation shuts off the autophagic process. In spite of its role as a self-digestion mechanism, autophagy is mainly activated to protect against cell death \[[@pone.0164115.ref005]\]. However, just like in the case of the UPR, stimulation of autophagy can be required to activate the cell death machinery under certain circumstances \[[@pone.0164115.ref006]\].

Anthocyanin compounds, the main bioactive components found in muscadine grape skin extract (MSKE) from the muscadine grape (*Vitis rotundifolia*), inhibit prostate cancer cell growth and promote apoptosis *in vitro* without toxicity to normal prostate epithelial cells \[[@pone.0164115.ref007]\]. Unlike other grape varieties, the phytochemical constituents of muscadine grapes have a higher concentration of anthocyanin 3,5-diglucosides, ellagic acid, and ellagic acid precursors \[[@pone.0164115.ref008]\]. In the case of purple skinned muscadine grapes, the anthocyanins are primarily delphinidin-3,5-diglucoside; cyanidin-3,5-diglucoside; and petunidin-3,5-diglucoside \[[@pone.0164115.ref008]\]. Anthocyanin 3,5 diglucosides are known to inhibit invasion in human hepatoma cells \[[@pone.0164115.ref009]\], and induce apoptosis and inhibit invasion in colorectal cancer cells \[[@pone.0164115.ref010]\]. MSKE has been shown to decrease tumor incidence, promote growth inhibition and stimulate cell death in various human cancer cell lines \[[@pone.0164115.ref007]\]. It can also revert the epithelial mesenchymal transition process \[[@pone.0164115.ref011]\]. Furthermore, the *in vivo* therapeutic effects of MSKE against prostate adenocarcinoma (PCa) are currently being investigated in a clinical trial \[[@pone.0164115.ref012]\].

In this study, proteomics, Western blot, acridine orange, Annexin V and TUNEL staining were used to determine global effects of MSKE on prostate cancer cells using C4-2 cells as a model. Our results revealed that MSKE regulated the expression of proteins important for ER stress response (GRP78, PDIA4, PDIA6, EIF2, EIF4 and Ire-1 alpha) and autophagy (ACIN1, PI4KA, PGK2 and MTDH). Pro-apoptotic markers were up-regulated, while anti-apoptotic protein BCL2 was down-regulated in the presence of MSKE; these effects were antagonized by co-treatment with chloroquine, suggesting that MSKE may promote ER stress-driven autophagic response leading to apoptosis.

Materials and Methods {#sec002}
=====================

Cell Culture, Reagents and Antibodies {#sec003}
-------------------------------------

C4-2 human prostate cells were grown in RPMI (Lonza, Alpharetta, GA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Flowery Branch, GA) and 1 × penicillin-streptomycin solution (Mediatech, Manassas, VA) at 37°C in a humidified incubator with 5% CO~2~. MSKE, which is composed mainly of anthocyanins, was prepared as previously described \[[@pone.0164115.ref007]\]. The protease inhibitor cocktail was purchased from Roche Molecular Biochemicals (Indianapolis, IN) and used according to the manufacturer's instructions. Chloroquine (autophagy inhibitor) was purchased from Sigma Aldridge.(St. Louis, MO). Annexin V/cell death apoptosis kit was purchased from Thermo Fisher Scientific (Waltham, MA).

Gel-free Isobaric Labeling Tandem Mass Tag Quantitative Proteomic Profiling of C4-2 Cells Treated with MSKE {#sec004}
-----------------------------------------------------------------------------------------------------------

### Cell lysis and protein extraction {#sec005}

Cells were plated on 150 cm^2^ culture plates at a cell density of 5 × 10^6^ and treated the following day with 20 μg/ml MSKE for 72 h. Cells treated with 0.1% ethanol were used as controls. Proteins were extracted with RIPA buffer (1.5 M Tris pH 8.8, 1.75 g NaCl, 2 mL sodium dodecyl sulfate 10%, 2 mL Triton X-100; all reagents from Thermo Fisher Scientific, Waltham, MA). The cells were incubated on ice for 30 min, followed by 5 min sonication and centrifugation at 20,000 rpm for 5 min in preparation for protein extraction. Protein concentration was calculated on microtiter plates by measuring the absorbance at 595 nm of samples containing a commercial protein assay (Bio-Rad Laboratories, Hercules, CA) supplemented with 10 μL of phosphatase inhibitor cocktail and 10 μL of protease inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN).

### Reduction, alkylation, and trypsin digestion {#sec006}

Aliquots with 100 mg of proteins from each sample were added to 100 ml of 200 mM triethyl ammonium bicarbonate TEAB (Sigma-Aldrich, St. Louis, MO). Reduction was performed by adding 5 ml of 200 mM tris (2-carboxyethyl) phosphine TCEP (Sigma-Aldrich, St. Louis, MO) to each replicate and incubating for 1 h at 55°C. Alkylation was carried out by adding 5 ml of 375 mM iodoacetamide (Bio-Rad Laboratories, Hercules, CA) to each sample and incubating for 30 min at room temperature. After alkylation, 1 ml of pre-chilled acetone was added and precipitation was allowed to proceed for 3 h at 20°C. Acetone-precipitated protein pellets were suspended in 100 ml of 200 mM TEAB and digested overnight at 37°C with 2.5 μg of sequencing grade modified trypsin (Promega Corp., Madison, WI) as previously described \[[@pone.0164115.ref013],[@pone.0164115.ref014]\].

Isobaric Labeling with Tandem Mass Tag {#sec007}
--------------------------------------

Tandem mass tag TMT with varying molecular weights *(126 \~ 131)* (Thermo Scientifc, Waltham, MA) were applied as isobaric labels for the comparison of differential protein expression between C4-2 cells treated with ethanol (0.1%) and C4-2 treated with 20 μg/ml MSKE. Six digested samples were individually labeled with TMT^6^ reagents according to the manufacturer's protocols. Three control (ethanol-treated) samples: TMT-126 (batch 1), TMT-127 (batch 2), and TMT-128 (batch3); and three MSKE-treated samples: TMT-129 (batch 1), TMT-130 (batch 2), and TMT-131 (batch3) were used in the studies. The labeled peptide mixtures were combined at equal ratios.

### Fractionation of labeled peptide mixture by using a strong cation exchange column {#sec008}

The TMT-labeled peptide mixture was fractionated with a strong cation exchange SCX column (Thermo Fisher Scientific, Waltham, MA) on a Shimadzu 2010 high performance liquid chromatography (HPLC) equipped with an ultraviolet detector (Shimadzu, Columbia, MD) and a mobile phase consisting of buffer A (5 mM KH~2~PO~4~, 25% acetonitrile, pH 2.8) and buffer B (buffer A plus 350 mM KCl). The column was equilibrated with buffer A for 30 min before sample injection. A mobile phase gradient at a flow rate of 1.0 ml/min was set as follows: 1) 0 \~ 10 min: 0% buffer B; 2) 10 \~ 40 min: 0 \~ 25% buffer B; 3) 40 \~ 45 min: 25 \~ 100% buffer B; 4) 45 \~ 50 min: 100% buffer B; 5) 50 \~ 60 min: 100 \~ 0% buffer B; and 6) 60 \~ 90 min: 0% buffer B. Sixty fractions were initially collected, lyophilized, and combined into 10 final fractions based on SCX chromatogram peaks.

### Desalination of fractionated samples {#sec009}

A C~18~ solid phase extraction SPE column (Thermo Fisher Scientific, Waltham, MA) was used to desalt all collected fractions as previously described \[[@pone.0164115.ref015]\]. Briefly, the 10 combined fractions were each adjusted to a final volume of 1 ml in a 0.25% trifluoroacetic acid TFA aqueous solution. The C~18~ SPE column was preconditioned with 1 ml acetonitrile and eluted in approximately 3 min before it was rinsed with 3 × 1 ml 0.25% TFA. The fractions were loaded on to the top of the SPE cartridge column slowly, and were reloaded once again to decrease lost peptide during column binding. Columns were washed with 4 × 1 ml 0.25% TFA aliquots before the peptides were eluted with 3 × 400 μl 80% acetonitrile/0.1% formic acid (aqueous). The eluted samples were lyophilized prior to the liquid chromatography mass spectrometry LC-MS/MS analysis.

### LC-MS/MS analysis {#sec010}

Peptides were analyzed on an LTQ-Orbitrap XL (Thermo Fisher Scientific, Waltham, MA) instrument interfaced with an Ultimate 3000 Dionex LC system (Dionex, Sunnyvale, CA). High mass resolution was utilized for peptide identification and high-energy collision dissociation (HCD) was used for reporter ion quantification as previously described \[[@pone.0164115.ref015]\]. Briefly, the reverse phase LC system contained a peptide Cap-Trap cartridge (0.5 × 2 mm) (Michrom BioResources, Auburn, CA) and a pre-packed BioBasic C~18~ PicoFrit analytical column (75 μm i.d. × 15 cm length, New Objective, Woburn, MA) fitted with a FortisTip emitter tip. Samples were loaded onto the trap cartridge and washed with mobile phase A (98% H~2~O, 2% acetonitrile, and 0.1% formic acid) for concentration and desalting. Peptides were eluted over 180 min from the analytical column via the trap cartridge by using a linear gradient of 6 to 100% mobile phase B (20% H~2~O, 80% acetonitrile, and 0.1% formic acid) at a flow rate of 0.3 μl/min.

The Orbitrap mass spectrometer was operated in a data-dependent mode in which each full MS scan (60,000 resolving power) was followed by six MS/MS scans where the three most abundant molecular ions were dynamically selected and fragmented by collision-induced dissociation with a normalized collision energy of 35% and subsequently scanned by HCD-MS^2^ with a collision energy of 45% as previously described \[[@pone.0164115.ref015]\]. Only the 2+, 3+, and 4+ ions were selected for fragmentation by collision-induced dissociation and HCD.

Database Search and TMT Quantification {#sec011}
--------------------------------------

The protein search algorithm SEQUEST was used to identify unique protein peptides using the Proteome Discoverer data processing software (version 1.2, Thermo Fisher Scientific, Waltham, MA). The ratios of TMT reporter ion abundances in MS/MS spectra generated by HCD from raw data sets were used For TMT quantification. Fold changes in proteins between control and treatment were calculated as previously described \[[@pone.0164115.ref015]\].

Western Blot {#sec012}
------------

20--30 μg of proteins extracted with RIPA buffer were analyzed by SDS PAGE and transferred to a nitrocellulose membrane. Membranes were blocked with 5% non-fat dry milk in 1 × TBST buffer (BioRad, Hercules, CA) and incubated with primary antibodies overnight at 4°C. The following primary antibodies were used at a 1:1000 dilution LC3B, cleaved caspase-3, cleaved caspase-7, BAX, and BCL2 (Cell Signaling Technologies Danvers, MA.), anti-caspase-12, Ire-1α, GRP78, DFF45, and PARP (Abcam, Cambridge, MA). Anti-β-actin (1:500, Sigma-Aldrich, St. Louis, MO) were used as a loading control. Horseradish peroxidase (HRP)-conjugated secondary antibodies (Sigma Aldrich, St Louis, MO) were used and protein bands were visualized by a chemiluminescence method using the SuperSignal West Femto Maximum Sensitivity Substrate kit (Thermo Fisher Scientific, Waltham, MA). Images were analyzed with the ImageJ image processing program version 1.50b (National Institutes of Health, Bethesda, MD) to access the differential expression of key ER stress and apoptotic markers.

Analysis of Autophagy {#sec013}
---------------------

Acridine Orange (AO) was used to analyze autophagy. Briefly, 5 × 10^3^ cells were plated into Nunc 8-well chamber slides (Bio-Tek Instruments, Winooski, VT). Cells were serum-starved for 4 h and treated with increasing concentrations (0 μg/mL, 5 μg/mL, 10 μg/mL or 20 μg/mL) of MSKE for 72 h. Fixation was performed with methanol/ethanol (1:1 volume) for 5 min, followed by washes with 1 × PBS. Cells were exposed to 5 μg/ml AO for 15 min at 37°C, washed with 1 × PBS, and counterstained with 1 μg/ml DAPI (Santa Cruz Biotechnology, Santa Cruz, CA) before they were fixed with Fluorogel mounting medium (Electron Microscopy Sciences, Hatfield, PA). Co-treatments with the autophagy inhibitor (20 μM chloroquine) for 72 h was also performed. Fluorescence microscopy was performed at 40 × oil magnification on a Zeiss fluorescence microscope equipped with the AxioVision (release 4.8) imaging software and the ApoTome.2 optical sections system (Carl Zeiss Microscopy GmbH, Jenna, Germany).

Immunofluoresence for LC3B {#sec014}
--------------------------

5 × 10^3^ cells were plated into Nunc 8-well chamber slides (Bio-Tek Instruments, Winooski, VT). Cells were serum-starved for 4 h and treated with 0 μg/mL or 20 μg/mL of MSKE with or without 20 μM chloroquine co-treatment for 72 h. Fixation was performed with methanol/ethanol (1:1 volume) for 5 min, followed by washes with 1 × PBS. Subsequently, slides were incubated with primary antibody (LC3B) at 1:50dilution in Dako antibody diluent solution for 1 h at room temp. Slides were washed with 1× TBS-T (Dako, Camarillo, CA), then incubated with secondary antibody in the dark for 1 h at room temp. Anti-rabbit Oregon green 488 was utilized as a secondary, and slides were then counterstained with 1 μg/ml DAPI (Santa Cruz Biotechnology, Santa Cruz, CA) before they were fixed with Fluorogel mounting medium (Electron Microscopy Sciences, Hatfield, PA). Fluorescence microscopy was performed at 40 × oil magnification on a Zeiss fluorescence microscope equipped with the AxioVision (release 4.8) imaging software and the ApoTome.2 optical sections system (Carl Zeiss Microscopy GmbH, Jenna, Germany).

TUNEL Assay {#sec015}
-----------

The terminal deoxynucleotidyl transferase (TdT) dUTP nick-end tabeling (TUNEL) assay was used to detect apoptosis. Briefly, 5 × 10^3^ cells were plated into 16-well Nunc chamber slides (Bio-Tek, Winooski, VT). Cells were serum starved for 4 h and treated with increasing concentrations of MSKE (0 μg/mL, 5 μg/mL, 10 μg/mL or 20 μg/mL) for 72 h. The cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% sodium citrate and 0.1% Triton X-100. DNA fragmentation was determined by TUNEL according to the manufacturer's instructions (Roche Applied Science, Penzberg, Germany) prior to counterstaining with 1 μg/ml DAPI (Santa Cruz Biotechnology, Santa Cruz, CA). Slides were mounted with Fluorogel mounting medium (Electron Microscopy Sciences, Hatfield, PA) and visualized under 40 × oil magnification on a Zeiss fluorescence microscope equipped with the AxioVision (release 4.8) imaging software and the ApoTome.2 optical sections system (Carl Zeiss Microscopy GmbH, Jenna, Germany).

Annexin V/Cell Death Apoptosis Kit {#sec016}
----------------------------------

Annexin V was also used to detect apoptosis. Briefly C4-2 Cells were serum starved for 4 h and treated with different concentrations of MSKE (0 μg/mL, 5 μg/mL) for 72 h, with or without 20 μM chloroquine. Apoptosis was assessed by Alexa Fluor 488 Annexin V and propidium iodide double staining and flow cytometry was performed using Accuri C6 Flow Cytometer (Accuri Cytometers Inc., Ann Arbor, MI.) according to the manufacterer instructions. Cells that stained positive for Annexin V- Alexa Fluor 488 and negative for PI (Alexa Fluor 488^+^/PI^-^) were considered to be undergoing early apoptosis; Alexa Fluor 488^+^/PI^+^ were considered as late apoptosis; Alexa Fluor 488^-^/PI^-^ considered non-apoptotic (viable). Experiments were performed in triplicate in two independent experiments, and a representative result displayed in the form of early/late apoptosis graphs.

Statistical Analysis {#sec017}
--------------------

Cytotoxicity assays and proteomics analyses were performed in triplicate, and similar results were obtained on at least three separate studies. Statistical analysis was performed using paired or unpaired t-tests, as appropriate, using the GraphPad PRISM v6.03 statistical software (GraphPad Software, La Jolla, CA). A *p* value of ≤ 0.05 was considered statistically significant and all data are presented as means ± standard error and range.

Results {#sec018}
=======

Proteomic Profiling of C4-2 Cells Treated with MSKE with a Gel-Free Isobaric Labeling TMT Quantitative Proteomic Approach {#sec019}
-------------------------------------------------------------------------------------------------------------------------

The differential expression of proteins between untreated (0.1% ethanol) and treated (20 μg/ml MSKE) C4-2 cells was determined based on a gel-free isobaric labeling TMT quantitative proteomic approach for further validation and identification of novel proteins. Over 1,855 proteins were identified from control and treated C4-2 cell lysates. Among them, 465 significantly differentially expressed proteins contained TMT signals that were used to determine protein expression ratios between treated and control C4-2 cells. Proteins up-regulated or down-regulated at least 1.2 fold were organized according to biological processes ([Fig 1](#pone.0164115.g001){ref-type="fig"}). The detailed information including protein ID, gene name, number of amino acids, molecular weight, calculated pI, description, coverage samples, protein expression, change folds, and p-values are shown in [S1 Table](#pone.0164115.s001){ref-type="supplementary-material"}. Proteins that had a fold change of at least 1.2 and p-values ≤ 0.05 were closely examined and are listed in [Table 1](#pone.0164115.t001){ref-type="table"}. MSKE-treated C4-2 cells expressed 254 up-regulated and 211 down-regulated proteins when compared to C4-2 control cells.

![TMT labeled proteins identified by MS and organized according to biological processes.\
Fig 1 shows proteins up-regulated or down-regulated at least 1.2 fold in C4-2 cells treated with 20 μg/ml MSKE as identified by the MASCOT database.](pone.0164115.g001){#pone.0164115.g001}
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###### Differentially expressed proteins in MSKE-treated and control cultures.

![](pone.0164115.t001){#pone.0164115.t001g}

  Description                                                                                     Score      P-value       Gene Symbol   Σcoverage   Change Fold   MW \[kDa\]   calc. pI
  ----------------------------------------------------------------------------------------------- ---------- ------------- ------------- ----------- ------------- ------------ ----------
  **APOPTOSIS**                                                                                                                                                                 
  Peptidyl-prolyl cis-trans isomerase F, mitochondrial                                            85.79      2.63417E-09   PPIF          21.26       1.23          22.03        9.38
  Aldo-keto reductase family 1 member C1                                                          20.02      0.009954054   AKR1C1        5.45        1.88          24.94        7.49
  PAX3- and PAX7-binding protein 1                                                                31.82      0.000657658   PAXBP1        3.13        -1.43         57.40        5.25
  \*annexin A4                                                                                    220.76     8.39334E-23   ANXA4         20.87       -1.20         36.06        6.13
  Rho guanine nucleotide exchange factor (GEF) 16                                                 97.39      1.82266E-10   ARHGEF16      12.33       -1.29         17.10        6.13
  BCL2-associated transcription factor 1                                                          30.77      0.000837529   BCLAF1        3.64        -1.23         52.89        11.22
  Cyclin-dependent kinase 5                                                                       31.84      0.000654636   CDK5          5.48        -1.20         33.28        7.66
  ARL-6-interacting protein 1                                                                     647.58     1.7459E-65    CG10326       18.54       1.32          17.15        7.96
  \*Cytochrome c oxidase subunit 4 isoform 1, mitochondrial                                       57.86      1.63682E-06   COX4I1        13.02       1.28          19.56        9.51
  \*Cytochrome c oxidase subunit 7A2, mitochondrial                                               107.11     1.94405E-11   COX7A2        15.66       1.23          9.39         9.76
  casein kinase 2, alpha 1 polypeptide                                                            103.29     4.68943E-11   CSNK2A1       11.95       -1.20         45.28        7.94
  \*Catenin delta-1                                                                               818.43     1.43523E-82   CTNND1        19.21       -1.29         90.34        7.03
  Drebrin-like protein                                                                            45.33      2.93089E-05   DBNL          3.4         -1.20         43.01        5.03
  Diablo homolog, mitochondrial                                                                   29.52      0.001116863   DIABLO        37.66       1.46          8.84         5.01
  Dynein light chain 2, cytoplasmic                                                               163.12     4.87128E-17   DYNLL2        32.58       -1.23         10.34        7.37
  elongation factor 1-delta isoform 4                                                             734.76     3.34299E-74   EEF1D         36.19       1.29          28.54        4.92
  Glutamate-cysteine ligase, modifier subunit, isoform CRA_a                                      140.93     8.07457E-15   GCLM          18.5        1.32          28.60        6.02
  Growth/differentiation factor 15                                                                188.91     1.28552E-19   GDF15         14.29       1.32          34.12        9.66
  \*Lactoylglutathione lyase                                                                      795.53     2.79874E-80   GLO1          55.62       -1.20         19.03        6.05
  Golgi phosphoprotein 3                                                                          61.95      6.37832E-07   GOLPH3        12.85       -1.24         32.91        6.71
  High mobility group protein B1                                                                  757.12     1.9406E-76    HMGB1         39.53       -1.27         24.88        5.74
  lamin-B1 isoform 2                                                                              55.31      2.94217E-06   LMNB1         2.66        1.24          43.00        5.12
  mitogen-activated protein kinase 3                                                              106.76     2.10863E-11   MAPK3         9.68        -1.22         17.92        8.70
  Macrophage migration inhibitory factor                                                          316.04     2.48889E-32   MIF           55.65       -1.26         12.47        7.88
  Cytochrome c oxidase subunit 2                                                                  40.84      8.24138E-05   MT-CO2        4.41        1.44          25.55        4.82
  NEDD8-activating enzyme E1 regulatory subunit isoform c                                         86.98      2.00638E-09   NAE1          5.17        1.27          50.59        5.27
  occludin                                                                                        78.58      1.38788E-08   OCLN          10.5        -1.64         23.31        6.06
  \*Programmed cell death protein 6                                                               428.90     1.28687E-43   PDCD6         9.63        1.31          15.57        8.19
  Prohibitin                                                                                      1313.07    4.9365E-132   PHB           64.34       1.23          29.79        5.76
  Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1                                          28.56      0.001393157   PIN1          9.2         -1.60         18.23        8.82
  Protein kinase C delta type                                                                     88.67      1.35752E-09   PRKCD         6.51        -1.35         77.45        7.75
  Phosphoserine aminotransferase                                                                  1228.55    1.397E-123    PSAT1         48.67       1.26          45.33        9.03
  Tyrosine-protein phosphatase non-receptor type6                                                 73.96      4.01791E-08   PTPN6         3.43        -1.20         66.19        7.23
  \*Ras-related protein Rab-21                                                                    116.33     2.32652E-12   RAB21         4.89        1.20          24.33        7.94
  \*Ras-related protein Rab-5A                                                                    157.52     1.76979E-16   RAB5A         12.44       1.27          22.16        8.82
  \*Ras-related protein Rab-5B                                                                    220.12     9.73258E-23   RAB5B         17.21       1.27          23.69        8.13
  \*Ras-related C3 botulinum toxin substrate 1                                                    66.40      2.29241E-07   RAC1          11.98       1.22          21.44        8.50
  Sigma non-opioid intracellular receptor 1                                                       32.66      0.000542001   SIGMAR1       6.42        -1.21         21.00        5.45
  Guanine nucleotide exchange factor VAV2                                                         25.09      0.00309803    VAV2          1.91        -1.27         96.97        6.90
  glycogen synthase kinase 3 beta                                                                 37.06      0.000196789   GSK3B         20.19       -1.25         11.56        8.02
  **AUTOPHAGY**                                                                                                                                                                 
  \*apoptotic chromatin condensation inducer in the nucleus isoform 3                             124.92     3.21851E-13   ACIN1         3.23        -1.60         147.30       6.73
  \*Protein LYRIC                                                                                 25.49      0.00282488    MTDH          3.04        1.91          57.49        9.54
  \*Phosphoglycerate kinase 2                                                                     651.02     7.91169E-66   PGK2          20.14       -1.22         44.77        8.54
  \*Phosphatidylinositol 4-kinase alpha                                                           27.37      0.001832314   PI4KA         0.93        1.19          231.17       6.87
  Ubiquilin-4                                                                                     29.37      0.001156112   UBQLN4        5.49        1.44          63.81        5.22
  **CELL PROLIFERATION**                                                                                                                                                        
  ADP-ribosylation factor-like protein 8A                                                         72.86      5.17257E-08   ARL8A         9.14        -1.37         21.40        7.77
  BolA-like protein 2                                                                             150.26     9.41588E-16   BOLA2         23.03       -1.28         16.92        8.19
  Calcium-binding protein 39                                                                      62.81      5.24105E-07   CAB39         6.16        -2.43         39.84        6.89
  DEAD (Asp-Glu-Ala-Asp) box helicase 5                                                           197.54     1.76228E-20   DDX5          18.82       -1.24         51.70        9.03
  Deoxyribonucleoside 5\'-monophosphate N-glycosidase                                             160.14     9.68456E-17   DNPH1         29.31       1.30          19.10        5.05
  Eukaryotic peptide chain release factor GTP-binding subunit ERF3A                               118.28     1.48531E-12   GSPT1         6.01        1.20          55.72        5.62
  Nucleolar GTP-binding protein 1                                                                 33.06      0.000494311   GTPBP4        2.12        -1.23         60.01        9.39
  \*HEAT SHOCK FACTOR PROTEIN 1                                                                   81.23      7.53356E-09   HSF1          5.25        -1.46         31.92        5.38
  Ragulator complex protein LAMTOR2                                                               28.86      0.00130017    LAMTOR2       14.4        1.60          13.50        5.40
  \*minichromosome maintenance complex component 2                                                146.21     2.39378E-15   MCM2          6.81        -1.56         91.22        6.43
  DNA replication licensing factor MCM3                                                           317.45     1.79731E-32   MCM3          13.78       -1.25         85.59        6.15
  DNA replication licensing factor MCM4                                                           82.29      5.90347E-09   MCM4          4.86        -1.55         92.66        6.98
  minichromosome maintenance complex component 5                                                  184.10     3.8897E-19    MCM5          8.68        -1.51         77.54        8.60
  DNA replication licensing factor MCM6                                                           95.87      2.58985E-10   MCM6          36.14       -1.63         9.53         4.41
  MCM7 isoform 2                                                                                  65.31      2.94243E-07   MCM7          4.24        -1.28         60.60        6.25
  N-myc downstream regulated 1                                                                    559.73     1.06484E-56   NDRG1         20.37       -1.37         35.27        6.34
  Nucleolar and coiled-body phosphoprotein 1                                                      262.61     5.48094E-27   NOLC1         11.44       1.24          73.56        9.47
  protein phosphatase, Mg2+/Mn2+ dependent, 1G                                                    333.88     4.09025E-34   PPM1G         7.75        -1.23         57.31        4.34
  protein phosphatase 1 regulatory subunit 12A isoform b                                          148.47     1.42272E-15   PPP1R12A      3.5         1.61          105.58       5.38
  protein phosphatase 1, regulatory subunit 8                                                     85.59      2.76058E-09   PPP1R8        10.24       -1.49         22.27        5.92
  Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform               372.95     5.06492E-38   PPP2R2A       13.42       -1.24         51.66        6.20
  Delta-3 of Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta              41.00      7.94328E-05   PPP2R5D       2.42        1.52          58.42        6.77
  protein phosphatase 3, regulatory subunit B, alpha                                              50.17      9.61612E-06   PPP3R1        11.25       -1.35         18.20        4.92
  protein kinase, AMP-activated, gamma 1 non-catalytic subunit                                    61.42      7.2062E-07    PRKAG1        7.69        -1.28         28.27        7.02
  spindle pole body component 24 homolog (SPBC24), mRNA                                           40.85      8.22243E-05   SPC24         11.26       -1.24         17.30        4.93
  Testin                                                                                          32.01      0.000629506   TES           5.59        1.59          20.64        6.48
  \*E3 ubiquitin-protein ligase UBR5                                                              120.37     9.17712E-13   UBR5          1.5         1.21          308.38       5.85
  ZW10 protein                                                                                    55.91      2.56448E-06   ZW10          2.98        1.36          76.76        6.32
  **CYTOSKELETAL**                                                                                                                                                              
  Neuroblast differentiation-associated protein AHNAK                                             254.32     3.7017E-26    AHNAK         10.05       -1.24         628.70       6.15
  actin-related protein 2/3 complex subunit 4 isoform b                                           27.12      0.001940886   ARPC4         10.26       -1.21         9.55         7.52
  Actin-related protein 2/3 complex subunit 5                                                     42.98      5.03501E-05   ARPC5         9.63        1.37          14.80        5.06
  CCDC88A protein                                                                                 61.95      6.37733E-07   CCDC88A       0.33        1.21          207.67       5.97
  Calicin                                                                                         27.87      0.001633052   CCIN          2.38        -3.15         66.54        8.18
  Cytoskeleton-associated protein 5                                                               40.21      9.52796E-05   CKAP5         4.93        1.32          22.74        8.05
  CLIP-associating protein 2                                                                      105.22     3.00771E-11   CLASP2        1.81        1.31          138.78       8.34
  claudin domain-containing protein 1 isoform b                                                   28.75      0.001333521   CLDND1        5.07        1.43          31.03        6.11
  Protein cordon-bleu                                                                             22.69      0.005382698   COBL          0.55        1.61          136.60       8.07
  \*cortactin                                                                                     28.61      0.001377209   CTTN          9.81        1.69          29.60        4.91
  DmX-like protein 2                                                                              24.41      0.003622      DMXL2         0.2         -1.36         339.43       6.38
  DnaJ homolog subfamily B member 6                                                               35.27      0.000297167   DNAJB6        19.7        1.25          7.88         7.40
  Niban-like protein 1                                                                            147.68     1.7054E-15    FAM129B       5.73        -1.22         82.63        6.15
  Filamin-B                                                                                       2200.56    8.788E-221    FLNB          20.64       -1.22         275.50       5.78
  Huntingtin-interacting protein K                                                                59.27      1.18304E-06   HYPK          11.63       -1.57         14.66        4.93
  Intraflagellar transport protein 27 homolog                                                     36.74      0.000211836   IFT27         6.2         2.31          14.02        4.64
  Junction plakoglobin                                                                            400.46     8.9848E-41    JUP           14.63       -1.24         81.69        6.14
  Kinesin-like protein                                                                            26.05      0.002483133   KIF3C         0.89        1.91          75.75        7.15
  Kinesin light chain 2                                                                           23.07      0.004931738   KLC2          1.15        1.25          57.14        8.21
  Keratin, type II cytoskeletal 8                                                                 3479.34    0             KRT8          62.32       -1.27         53.67        5.59
  LIM domain and actin-binding protein 1                                                          44.21      3.79315E-05   LIMA1         3.09        1.48          43.16        8.51
  macrophage erythroblast attacher                                                                49.94      1.01391E-05   MAEA          19.63       -1.28         11.83        8.00
  Microtubule-associated proteins 1A/1B light chain 3 beta 2                                      32.17      0.000606736   MAP1LC3B2     11.2        1.68          14.62        8.68
  palmitoylated 5 (MAGUK p55 subfamily member 5)                                                  72.66      5.42001E-08   MPP5          8.05        -1.26         17.18        6.70
  Protein PRRC1                                                                                   161.42     7.21439E-17   PRRC1         6.97        1.22          46.67        5.83
  Radixin                                                                                         176.11     2.44856E-18   RDX           7.89        1.30          68.52        6.37
  Ras-related protein R-Ras                                                                       117.96     1.59848E-12   RRAS          12.84       -1.25         23.47        6.93
  Na+/H+ exchange regulatory co-factor (NHERF) mRNA                                               98.76      1.32928E-10   SLC9A3R1      14.65       -1.42         29.42        6.80
  spectrin, beta, non-erythrocytic 2                                                              35.29      0.000295801   SPTBN2        1.61        -1.48         105.60       7.75
  tubulin, beta 6 class V                                                                         1231.71    6.7485E-124   TUBB6         55.67       -1.22         44.57        4.93
  \*Alpha-taxilin                                                                                 32.11      0.000615177   TXLNA         2.56        1.37          61.85        6.52
  **ER STRESS**                                                                                                                                                                 
  Cystathionine gamma-lyase                                                                       306.48     2.24785E-31   CTH           13.3        1.47          39.48        6.90
  \*Translation initiation factor eIF-2B subunit alpha                                            33.77      0.000419759   EIF2B1        4.61        1.51          16.92        6.90
  Protein Niban                                                                                   67.07      1.96515E-07   FAM129A       3.02        1.44          103.07       4.78
  Mesencephalic astrocyte-derived neurotrophic factor                                             139.84     1.03761E-14   MANF          25.27       1.29          20.69        8.69
  B-cell receptor-associated protein 31                                                           389.58     1.10175E-39   BCAP31        22.36       1.21          27.97        8.44
  \*Eukaryotic translation initiation factor 4E-binding protein 1                                 124.81     3.30025E-13   EIF4EBP1      15.25       1.28          12.57        5.48
  Endoplasmic reticulum resident protein 29                                                       364.95     3.20115E-37   ERP29         26.05       1.30          28.98        7.31
  Endoplasmin                                                                                     6243.82    0             HSP90B1       52.93       1.30          92.41        4.84
  \*78 kDa glucose-regulated protein                                                              7582.64    0             HSPA5         60.24       1.67          72.29        5.16
  \*60 kDa heat shock protein, mitochondrial                                                      19539.31   0             HSPD1         82.02       1.23          61.02        5.87
  Protein disulfide-isomerase                                                                     1239.55    1.1085E-124   P4HB          49.46       1.38          32.13        8.51
  Protein disulfide-isomerase                                                                     3026.26    2.3635E-303   P4HB          58.07       1.37          57.08        4.87
  \*Protein disulfide-isomerase A4                                                                3139.65    0             PDIA4         53.18       1.21          72.89        5.07
  \*Protein disulfide-isomerase A6                                                                1106.04    2.4891E-111   PDIA6         31.35       1.26          47.81        5.08
  \*Thioredoxin-related transmembrane protein 2                                                   30.71      0.00084918    TMX2          10.47       1.22          29.62        8.65
  E3 UFM1-protein ligase 1                                                                        42.96      5.05825E-05   UFL1          3.93        1.20          57.55        6.30
  endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (Fragment)                59.25      1.1885E-06    HERPUD1       8.19        1.37          26.20        5.77
  **GENE EXPRESSION**                                                                                                                                                           
  acidic leucine-rich nuclear phosphoprotein 32 family member E isoform 3                         313.17     4.81956E-32   ANP32E        22.27       -1.43         25.11        3.74
  Ataxin-2-like protein                                                                           434.72     3.37392E-44   ATXN2L        1.14        1.54          102.83       8.63
  Barrier-to-autointegration factor                                                               382.78     5.27164E-39   BANF1         40.45       -1.36         10.05        6.09
  C5orf38 protein                                                                                 34.05      0.000393587   C5orf38       8.15        1.33          14.68        11.27
  chromobox homolog 1                                                                             157.35     1.8397E-16    CBX1          24.4        -1.22         19.31        5.02
  CD81 molecule                                                                                   122.31     5.88048E-13   CD81          21.51       -1.24         10.09        4.59
  Coiled-coil-helix-coiled-coil-helix domain-containing protein 2, mitochondrial                  45.54      2.79254E-05   CHCHD2        11.26       1.52          15.50        9.22
  UMP-CMP kinase isoform a                                                                        632.76     5.29998E-64   CMPK1         25          -1.22         25.84        7.97
  Cleavage and polyadenylation specificity factor subunit 7                                       48.60      1.37945E-05   CPSF7         10.55       1.32          26.13        9.51
  Probable ATP-dependent RNA helicase DDX6                                                        89.47      1.13097E-09   DDX6          8.28        1.24          54.38        8.66
  Enhancer of mRNA-decapping protein 4                                                            349.20     1.20135E-35   EDC4          11.86       -1.25         109.66       5.99
  Elongation factor 1-beta                                                                        352.91     5.11228E-36   EEF1B2        44.89       1.20          24.75        4.67
  Zinc phosphodiesterase ELAC protein 2                                                           37.70      0.000169824   ELAC2         3.79        -1.20         56.06        7.43
  EWS RNA-binding protein 1                                                                       149.95     1.01187E-15   EWSR1         9.42        -1.36         32.16        9.82
  G-rich sequence factor 1 isoform 2                                                              68.69      1.35317E-07   GRSF1         6.92        -1.34         36.59        5.69
  general transcription factor IIA, 1, 19/37kDa                                                   76.72      2.12814E-08   GTF2A1        18.64       -1.60         6.74         4.72
  General transcription factor IIF subunit 2                                                      59.04      1.24847E-06   GTF2F2        5.22        -1.28         28.36        9.23
  histone H2A.V isoform 2                                                                         969.32     1.16911E-97   H2AFV         16.67       1.44          12.14        10.46
  Heterogeneous nuclear ribonucleoprotein A/B                                                     289.20     1.20359E-29   HNRNPAB       17.86       1.25          30.28        7.91
  heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)        555.96     2.53589E-56   HNRNPD        50.89       -2.18         12.63        8.57
  insulin-like growth factor 2 mRNA binding protein 3                                             28.17      0.001524053   IGF2BP3       12.35       -1.20         8.89         5.78
  La ribonucleoprotein domain family, member 7                                                    58.03      1.57398E-06   LARP7         7.19        -1.43         38.18        9.32
  39S ribosomal protein L12, mitochondrial                                                        188.09     1.5512E-19    MRPL12        29.29       1.47          21.33        8.87
  myb-related protein A isoform 2                                                                 28.34      0.001465548   MYBL1         1.45        1.30          78.90        6.68
  Myosin Ic                                                                                       575.17     3.03883E-58   MYO1C         15.53       -1.25         92.27        8.87
  nuclear cap binding protein subunit 1, 80kDa                                                    34.35      0.000367282   NCBP1         29.27       -1.30         9.18         6.77
  NELF-D of Negative elongation factor C/D                                                        34.11      0.00038815    NELFCD        1.72        -1.88         65.44        5.10
  Cleavage and polyadenylation specificity factor subunit 5                                       63.27      4.70977E-07   NUDT21        27.31       -1.33         26.21        8.82
  Phosphorylated adapter RNA export protein                                                       29.12      0.001224616   PHAX          2.79        -1.25         44.38        5.40
  phosphatidylinositol-binding clathrin assembly protein isoform 4                                133.72     4.24178E-14   PICALM        8.53        -1.26         59.88        8.76
  Pentatricopeptide repeat-containing protein 3, mitochondrial                                    86.22      2.3862E-09    PTCD3         7.69        1.28          78.50        6.42
  Putative peptidyl-tRNA hydrolase PTRHD1                                                         33.65      0.000431519   PTRHD1        17.86       -1.26         15.80        9.10
  retinoblastoma binding protein 7                                                                33.52      0.000444631   RBBP7         7.69        -1.33         46.91        5.07
  RNA-binding protein 10 isoform 5                                                                53.58      4.38531E-06   RBM10         3.92        1.51          110.30       6.28
  Splicing factor 45                                                                              36.91      0.00020387    RBM17         4.99        1.20          44.93        5.97
  ATP-dependent DNA helicase Q1                                                                   47.07      1.9619E-05    RECQL         2.47        -1.46         73.41        7.88
  ribonuclease H2 subunit B isoform 2                                                             30.81      0.000829851   RNASEH2B      8.17        -1.39         28.99        8.82
  Ribonuclease P protein subunit p14                                                              68.05      1.56675E-07   RPP14         16.13       -1.29         13.68        7.75
  Ribonuclease P protein subunit p38                                                              74.83      3.28852E-08   RPP38         6.36        -1.32         31.81        9.92
  splicing factor 3A subunit 1 isoform 2                                                          117.45     1.79925E-12   SF3A1         7.01        1.21          81.63        5.34
  Nuclear receptor coactivator NC0A-62                                                            31.32      0.000737904   SNW1          2.67        1.20          43.31        9.70
  Splicing regulatory glutamine/lysine-rich protein 1                                             56.27      2.36048E-06   SREK1         1.97        1.21          59.35        10.39
  Serine/arginine repetitive matrix protein 1                                                     78.24      1.49833E-08   SRRM1         8.19        -1.24         102.27       11.84
  Splicing factor arginine/serine-rich 11                                                         25.87      0.002588213   SRSF11        6.25        1.34          13.13        6.28
  Splicing factor, arginine/serine-rich 5                                                         120.94     8.056E-13     SRSF5         25.81       -1.37         14.43        10.08
  Transcription elongation factor A protein 1                                                     91.04      7.86502E-10   TCEA1         17.28       1.29          33.95        8.38
  EKC/KEOPS complex subunit TPRKB                                                                 78.14      1.53358E-08   TPRKB         12.68       -1.31         16.08        6.30
  tRNA (guanine-N(1)-)-methyltransferase                                                          46.82      2.0797E-05    TRMT5         2.95        1.33          58.21        8.62
  Exportin-5                                                                                      28.18      0.001521507   XPO5          12.21       -1.20         136.22       5.80
  zinc finger, CCHC domain containing 8                                                           72.69      5.3827E-08    ZCCHC8        12.28       -1.52         18.10        4.65
  zinc finger protein 2 (Fragment)                                                                27.62      0.001729816   ZNF2          0.83        1.43          118.55       6.43
  Zinc finger protein 511                                                                         59.64      1.08643E-06   ZNF511        5.56        -1.51         28.25        7.66
  \*Zinc finger SWIM domain-containing protein 5                                                  15.31      0.029444216   ZSWIM5        0.59        -2.63         130.55       7.18
  dolichyl-diphosphooligosaccharide---protein glycosyltransferase subunit 2 isoform 2 precursor   35.79      0.000263633   RPN2          15.77       1.22          67.68        6.06
  **IMMUNE RESPONSE**                                                                                                                                                           
  Beta-defensin 119                                                                               25.85      0.002601985   DEFB119       7.14        -1.92         9.81         8.57
  F-box/LRR-repeat protein 8                                                                      27.08      0.001958845   FBXL8         6.2         1.53          14.20        6.99
  Guanine nucleotide-binding protein-like 1                                                       74.73      3.36284E-08   GNL1          4.2         1.80          28.69        4.69
  HLA class II histocompatibility antigen, DQB1\*0602 beta chain                                  25.92      0.002558586   HLA-DQB1      5.88        1.31          15.76        8.85
  Interferon regulatory factor 7                                                                  203.30     4.67539E-21   IRF7          4.53        1.48          42.25        5.34
  Dual specificity mitogen-activated protein kinase kinase 3                                      38.59      0.000138357   MAP2K3        5.66        1.33          36.15        6.25
  Macrophage-expressed gene 1 protein                                                             49.94      1.01391E-05   MPEG1         0.84        1.49          78.54        7.65
  \*G antigen family B member 1                                                                   116.72     2.13016E-12   PAGE1         19.86       -1.53         16.14        4.22
  \*Phosphoinositide 3-kinase regulatory subunit 4                                                24.48      0.003564511   PIK3R4        0.44        1.46          153.01       7.17
  Pirin                                                                                           158.71     1.3466E-16    PIR           7.24        1.31          32.09        6.92
  Parathymosin                                                                                    230.82     8.27378E-24   PTMS          22.55       1.44          11.52        4.16
  SAM domain and HD domain-containing protein 1                                                   60.21      9.52153E-07   SAMHD1        6.15        -1.49         69.40        7.20
  single immunoglobulin and toll-interleukin 1 receptor (TIR) domain                              81.02      7.90679E-09   SIGIRR        11.97       -1.33         15.50        4.86
  Serine/threonine-protein kinase TBK1                                                            60.83      8.26038E-07   TBK1          2.74        -1.39         83.59        6.79
  Zinc finger CCCH-type antiviral protein 1                                                       86.04      2.48886E-09   ZC3HAV1       3.58        -1.20         77.85        8.38
  **METABOLISM**                                                                                                                                                                
  Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial                                   112.09     6.18431E-12   AADAT         12.12       1.24          47.79        7.21
  Abhydrolase domain-containing protein 10, mitochondrial                                         35.49      0.000282488   ABHD10        13.73       1.23          33.91        8.57
  acyl-CoA thioesterase 9                                                                         49.12      1.22462E-05   ACOT9         9.56        -1.31         15.45        8.59
  Adenylate kinase isoenzyme 1                                                                    250.33     9.27582E-26   AK1           27.84       -1.20         21.62        8.63
  GTP:AMP phosphotransferase, mitochondrial isoform c                                             91.18      7.61682E-10   AK3           22.93       1.29          18.18        8.78
  Argininosuccinate synthase                                                                      548.15     1.52978E-55   ASS1          26.22       -1.35         50.79        8.40
  ATP synthase subunit beta, mitochondrial                                                        6847.36    0             ATP5B         72.78       1.20          56.52        5.40
  ATP synthase gamma chain                                                                        89.04      1.24654E-09   ATP5C1        8.8         1.32          27.50        7.42
  ATP synthase subunit epsilon-like protein, mitochondrial                                        32.85      0.0005188     ATP5EP2       13.73       1.31          5.80         10.14
  ATP synthase subunit b, mitochondrial                                                           198.92     1.28165E-20   ATP5F1        11.72       1.36          28.89        9.36
  ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (Subunit 9)                 247.94     1.60823E-25   ATP5G1        7.07        2.35          10.19        10.40
  ATP synthase-coupling factor 6, mitochondrial                                                   78.67      1.35831E-08   ATP5J         17.59       1.24          12.58        9.52
  ATP synthase subunit f, mitochondrial isoform 2d                                                42.39      5.76766E-05   ATP5J2        59.18       1.59          5.74         9.70
  ATP synthase subunit g, mitochondrial                                                           88.08      1.55639E-09   ATP5L         28.95       1.20          8.45         10.29
  ATP synthase subunit O, mitochondrial                                                           607.69     1.70258E-61   ATP5O         38.97       1.22          23.26        9.96
  ATP synthase mitochondrial F1 complexassembly factor 2, mitochondrial                           42.39      5.76766E-05   ATPAF2        21.19       -1.24         13.05        9.51
  ADP-ribosyl cyclase 2                                                                           49.30      1.17453E-05   BST1          1.89        1.21          35.70        7.80
  citrate lyase beta like (CLYBL), transcript variant 2, mRNA                                     25.67      0.002710192   CLYBL         1.99        1.43          32.83        8.29
  Coatomer subunit gamma-2                                                                        296.91     2.03587E-30   COPG2         7.23        -1.21         97.56        5.81
  Cubilin                                                                                         26.56      0.002208005   CUBN          0.28        1.26          398.48       5.35
  Lanosterol 14-alpha demethylase                                                                 31.32      0.000737904   CYP51A1       6.31        1.20          25.63        9.22
  Elongation factor 1-alpha 1                                                                     2876.54    2.2169E-288   EEF1A1        17.32       1.42          50.12        8.95
  Elongation factor 1-gamma                                                                       847.83     1.6494E-85    EEF1G         39.13       1.24          50.09        6.67
  Eukaryotic translation initiation factor 3 subunit H                                            219.98     1.0051E-22    EIF3H         12.78       1.29          39.91        6.54
  Eukaryotic translation initiation factor 3 subunit K                                            146.26     2.36701E-15   EIF3K         20.18       1.30          25.04        4.93
  eukaryotic translation initiation factor 4A2                                                    236.48     2.24941E-24   EIF4A2        40.61       -1.70         41.26        5.64
  Eukaryotic translation initiation factor 5                                                      355.38     2.89998E-36   EIF5          20.88       1.27          49.19        5.58
  Mitochondrial enolase superfamily member 1                                                      31.06      0.00078343    ENOSF1        4.29        -1.21         49.75        6.48
  Squalene synthase                                                                               308.02     1.57875E-31   FDFT1         19.27       1.28          47.25        6.54
  Fibronectin                                                                                     84.30      3.71838E-09   FN1           1.38        -1.75         222.84       5.68
  fibronectin 1 (FN1), transcript variant 5, mRNA                                                 84.30      3.71838E-09   FN1           2.96        -1.32         111.23       6.21
  Galactokinase                                                                                   65.27      2.97119E-07   GALK1         10.71       1.61          42.25        6.46
  N-acetylgalactosamine kinase                                                                    33.04      0.000496592   GALK2         4.15        1.39          47.60        6.19
  FAD-linked sulfhydryl oxidase ALR                                                               73.98      3.99945E-08   GFER          12.2        1.27          23.43        7.62
  Glutathione S-transferase                                                                       109.04     1.24616E-11   GSTA3         12.21       -1.22         19.73        9.16
  Glutathione S-transferase Mu 3                                                                  1530.92    8.0923E-154   GSTM3         56.44       -1.24         26.54        5.54
  Hydroxyacylglutathione hydrolase, mitochondrial                                                 32.51      0.000561048   HAGH          8.08        -1.26         28.84        7.33
  Histone acetyltransferase type B catalytic subunit                                              134.87     3.25617E-14   HAT1          5.39        -1.40         39.76        5.92
  Isopentenyl-diphosphate Delta-isomerase 1                                                       75.33      2.93089E-08   IDI1          15.86       1.24          26.30        6.34
  inositol-tetrakisphosphate 1-kinase                                                             28.46      0.001425608   ITPK1         12.5        -1.58         19.45        6.39
  L-lactate dehydrogenase A-like 6A                                                               362.00     6.31588E-37   LDHAL6A       7.23        -1.28         36.48        6.99
  Phospholysine phosphohistidine inorganic pyrophosphate phosphatase                              113.45     4.51551E-12   LHPP          7.78        -1.23         29.15        6.15
  lanosterol synthase isoform 3                                                                   54.26      3.7465E-06    LSS           3.07        1.49          74.17        6.46
  Leukotriene A-4 hydrolase                                                                       45.87      2.58821E-05   LTA4H         2.36        1.46          57.26        6.06
  LYR motif-containing protein 7                                                                  56.05      2.48146E-06   LYRM7         15.38       1.68          11.95        9.66
  NADP-dependent malic enzyme                                                                     1228.39    1.4492E-123   ME1           20.98       1.40          64.11        6.13
  NAD-dependent malic enzyme, mitochondrial isoform 2 precursor                                   53.87      4.10204E-06   ME2           5.01        1.52          53.55        8.54
  Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial                                155.89     2.57529E-16   MMAB          28.4        1.31          27.37        8.60
  Mannose-6-phosphate isomerase                                                                   289.43     1.1405E-29    MPI           18.68       -1.28         46.63        5.95
  39S ribosomal protein L53, mitochondrial                                                        45.67      2.70836E-05   MRPL53        13.39       1.65          12.10        8.76
  Arylamine N-acetyltransferase 1                                                                 68.56      1.39222E-07   NAT1          5.86        -1.28         33.88        6.54
  NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial                                    35.89      0.000257632   NDUFS1        3.27        1.61          66.88        5.38
  NADH dehydrogenase \[ubiquinone\] iron-sulfur protein 3, mitochondrial                          34.69      0.000339625   NDUFS3        19.23       1.77          8.60         8.03
  nitric oxide synthase interacting protein (NOSIP), mRNA                                         26.13      0.002437811   NOSIP         6.63        -1.81         17.93        8.00
  nucleoporin 133kDa                                                                              169.20     1.2026E-17    NUP133        7.19        -1.26         120.30       5.15
  Nuclear pore complex protein Nup205                                                             41.85      6.53131E-05   NUP205        2.83        -1.40         227.78       6.19
  Nuclear pore complex protein Nup93                                                              25.65      0.002722701   NUP93         1.15        -1.25         79.83        6.18
  nucleoporin 98kDa                                                                               447.74     1.68228E-45   NUP98         6.9         -1.53         26.86        7.39
  propionyl-CoA carboxylase alpha chain, mitochondrial isoform c precursor                        24.30      0.003715352   PCCA          1.03        1.46          74.95        7.36
  phosphoacetylglucosamine mutase isoform 3                                                       113.80     4.17131E-12   PGM3          8.03        1.33          51.05        5.88
  Arfaptin-2                                                                                      31.82      0.000657658   POR           16.99       1.20          47.37        7.81
  Lipid phosphate phosphohydrolase 1                                                              29.39      0.0011508     PPAP2A        7.04        1.22          32.14        7.97
  Palmitoyl-protein thioesterase 1                                                                126.47     2.25388E-13   PPT1          9.48        -1.34         34.17        6.52
  glucosidase 2 subunit beta isoform 2                                                            450.79     8.33915E-46   PRKCSH        20.19       1.28          59.14        4.42
  Prosaposin                                                                                      1508.14    1.5356E-151   PSAP          21.76       -1.33         58.07        5.17
  Ran GTPase activating protein 1                                                                 115.42     2.87351E-12   RANGAP1       9.02        -1.35         57.74        4.53
  rap1 GTPase-GDP dissociation stimulator 1 isoform 6                                             90.06      9.85348E-10   RAP1GDS1      11.82       -1.20         56.50        5.44
  60S acidic ribosomal protein P2                                                                 1310.74    8.4427E-132   RPLP2         70.43       -1.29         11.66        4.54
  SUMO-activating enzyme subunit 1                                                                481.73     6.71984E-49   SAE1          18.79       -1.25         38.43        5.30
  Sec1 family domain-containing protein 1                                                         72.62      5.47514E-08   SCFD1         6.13        1.24          51.51        6.96
  Succinate dehydrogenase \[ubiquinone\] flavoprotein subunit, mitochondrial                      344.95     3.19778E-35   SDHA          9.61        1.26          63.53        7.24
  Protein transport protein Sec24B                                                                38.99      0.000126098   SEC24B        0.89        -1.48         133.54       7.39
  serine hydroxymethyltransferase, mitochondrial isoform 3                                        1864.72    3.3762E-187   SHMT2         49.28       1.24          53.42        8.15
  Monocarboxylate transporter 1                                                                   106.48     2.24967E-11   SLC16A1       10.42       -1.29         51.80        8.50
  Tricarboxylate transport protein, mitochondrial                                                 73.34      4.63657E-08   SLC25A1       7.4         1.20          33.99        9.89
  Calcium-binding mitochondrial carrier protein Aralar2                                           64.84      3.27874E-07   SLC25A13      8.11        1.21          62.21        9.01
  solute carrier organic anion transporter family member 1C1 isoform 3                            30.95      0.000803526   SLCO1C1       0.9         1.52          73.22        8.85
  Translocon-associated protein subunit alpha                                                     271.19     7.59987E-28   SSR1          8.88        1.25          29.36        4.61
  Translocon-associated protein subunit delta                                                     141.51     7.06092E-15   SSR4          17.5        1.40          13.06        7.50
  UDP-N-acetylhexosamine pyrophosphorylase                                                        80.69      8.52774E-09   UAP1          2.97        1.23          56.99        6.38
  UTP---glucose-1-phosphate uridylyltransferase                                                   25.07      0.003111716   UGP2          4.02        1.23          55.64        7.88
  Cytochrome b-c1 complex subunit 9                                                               57.97      1.5948E-06    UQCR10        38.1        1.31          7.30         9.47
  Cytochrome b-c1 complex subunit 7                                                               94.76      3.34256E-10   UQCRB         21.62       1.22          13.52        8.78
  **OXIDATIVE STRESS**                                                                                                                                                          
  Cytoplasmic aconitate hydratase                                                                 179.53     1.11364E-18   ACO1          6.97        -1.36         98.34        6.68
  \*Retinal dehydrogenase 1                                                                       385.17     3.03767E-39   ALDH1A1       17.95       1.32          42.57        5.80
  \*Fatty aldehyde dehydrogenase                                                                  262.18     6.06001E-27   ALDH3A2       12.99       1.23          54.81        7.88
  Alkylated repair protein alkB                                                                   78.29      1.48152E-08   ALKBH5        5.48        -1.41         43.02        9.16
  aspartyl/asparaginyl beta-hydroxylase isoform f                                                 131.03     7.88327E-14   ASPH          4.39        2.23          83.22        4.92
  Cytochrome b561                                                                                 86.52      2.22693E-09   CYB561        4.38        1.45          27.54        8.56
  Cytochrome b5                                                                                   126.09     2.45962E-13   CYB5A         42.86       -1.22         11.26        5.14
  \*Dehydrogenase/reductase SDR family member 1                                                   67.71      1.69434E-07   DHRS1         6.07        1.31          33.89        7.83
  Glycine N-methyltransferase                                                                     39.20      0.000120226   GNMT          2.71        -1.25         32.72        7.02
  MOSC domain-containing protein 1, mitochondrial                                                 40.11      9.7499E-05    MARC1         13.89       -1.23         28.42        7.31
  3-mercaptopyruvate sulfurtransferase                                                            72.72      5.34203E-08   MPST          14.48       1.23          33.16        6.60
  Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial              33.26      0.000472063   MTHFD2        5.41        2.00          23.85        9.76
  Myb-binding protein 1A                                                                          64.54      3.5156E-07    MYBBP1A       0.83        -1.29         148.76       9.28
  NADH dehydrogenase \[ubiquinone\] iron-sulfur protein 8, mitochondrial                          40.43      9.05733E-05   NDUFS8        8.18        1.86          12.40        9.98
  \*NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 3, mRNA                           513.20     4.78822E-52   NQO1          52.48       1.28          22.78        8.50
  Prolyl 4-hydroxylase subunit alpha-2                                                            36.08      0.000246604   P4HA2         2.25        1.41          60.59        5.71
  Protoporphyrinogen oxidase                                                                      87.40      1.8197E-09    PPOX          6.98        1.26          46.81        7.31
  Pyrroline-5-carboxylate reductase 2                                                             93.93      4.04761E-10   PYCR2         9.38        1.23          33.62        7.77
  Retinol dehydrogenase 14                                                                        64.68      3.40408E-07   RDH14         7.14        1.44          36.84        8.79
  \*Sideroflexin-1                                                                                318.98     1.26412E-32   SFXN1         32.61       1.21          35.60        9.07
  \*STEAP family member 2, metalloreductase                                                       90.06      9.86169E-10   STEAP2        6.7         -1.47         45.95        8.91
  **PROTEOLYTIC**                                                                                                                                                               
  ADAM metallopeptidase domain 9                                                                  26.77      0.002103778   ADAM9         3.82        -1.34         69.28        6.65
  asparagine synthetase \[glutamine-hydrolyzing\] isoform b                                       2335.19    3.0244E-234   ASNS          38.89       1.31          62.13        7.06
  Cyclin-dependent kinase 1                                                                       29.04      0.001247384   CDK1          8.33        -1.57         27.49        7.06
  \*Collagen type IV alpha-3-binding protein                                                      48.53      1.40281E-05   COL4A3BP      1.67        -1.40         67.96        5.47
  Cystatin-B                                                                                      190.50     8.90894E-20   CSTB          24.49       -1.82         11.13        7.56
  Farnesyl pyrophosphate synthetase like-4 protein (Fragment)                                     70.77      8.36775E-08   FDPS          8.62        -3.10         39.63        4.98
  PSMA\' of Glutamate carboxypeptidase 2                                                          414.93     3.21326E-42   FOLH1         9.24        -1.46         77.95        6.67
  Glucosamine---fructose-6-phosphate aminotransferase \[isomerizing\] 2                           148.17     1.52319E-15   GFPT2         6.6         -1.87         76.88        7.37
  Minor histocompatibility antigen H13                                                            60.58      8.74071E-07   HM13          6.57        1.21          36.79        6.68
  \*Hypoxia up-regulated protein 1                                                                2096.90    2.0428E-210   HYOU1         28.53       1.21          111.27       5.22
  Leucyl-cystinyl aminopeptidase                                                                  91.92      6.43211E-10   LNPEP         2.78        -1.26         114.99       5.78
  Mucosa-associated lymphoid tissue lymphoma translocation protein 1                              29.41      0.001145513   MALT1         1.97        -1.47         91.02        5.91
  E3 ubiquitin-protein ligase MARCH5                                                              27.45      0.001798871   MARCH5        3.6         1.69          31.21        8.70
  Neprilysin                                                                                      670.63     8.64906E-68   MME           20          -1.33         85.46        5.73
  neural precursor cell expressed, developmentally down-regulated 8                               101.64     6.8544E-11    NEDD8         40          -1.34         5.86         6.70
  aminopeptidase NPEPL1 isoform 3                                                                 158.36     1.45823E-16   NPEPL1        4.84        -1.22         50.50        6.52
  Ubiquitin thioesterase OTUB2                                                                    229.61     1.09388E-23   OTUB2         7.02        2.11          12.93        9.29
  \*OTU domain-containing protein 6B                                                              102.58     5.52077E-11   OTUD6B        14.58       -1.37         21.79        5.10
  Proteasome subunit beta type-6                                                                  117.00     1.9941E-12    PSMB6         25.1        1.20          25.34        4.92
  E3 ubiquitin/ISG15 ligase TRIM25                                                                166.22     2.38646E-17   TRIM25        7.14        -1.22         70.93        8.09
  Transcription intermediary factor 1-beta                                                        62.59      5.50752E-07   TRIM28        33.05       -1.23         88.49        5.77
  \*Ubiquitin-conjugating enzyme E2 variant 2                                                     369.35     1.16185E-37   UBE2V2        60.61       1.56          11.27        5.52
  E3 ubiquitin-protein ligase UBR2                                                                39.23      0.000119399   UBR2          4           -1.27         66.01        7.42
  Deubiquitinating protein VCIP135                                                                30.73      0.000845279   VCPIP1        0.57        -1.73         134.24       7.20
  X-prolyl aminopeptidase (Aminopeptidase P) 1, soluble                                           38.35      0.000146218   XPNPEP1       3.26        1.41          62.10        5.73
  **OTHER**                                                                                                                                                                     
  Armadillo repeat containing 2                                                                   36.31      0.000233884   ARMC2         9.41        2.12          9.41         6.92
  UPF0556 protein C19orf10                                                                        33.48      0.000448745   C19orf10      13.87       1.27          18.78        6.68
  CDGSH iron-sulfur domain-containing protein 3, mitochondrial                                    34.93      0.000321366   CISD3         10.24       1.24          14.21        10.55
  Protein FAM136A                                                                                 28.08      0.001555966   FAM136A       6.52        1.30          15.63        7.61
  hematological and neurological expressed 1                                                      60.68      8.55067E-07   HN1           9.35        -1.34         11.62        8.47
  kelch-like protein 35                                                                           27.78      0.001667247   KLHL35        1.2         -1.35         62.85        7.83
  Leucine-rich repeat-containing protein 47                                                       55.50      2.81838E-06   LRRC47        2.57        1.43          63.43        8.28
  Nucleoside diphosphate-linked moiety X motif 22                                                 1000.35    9.2264E-101   NUDT22        2.12        1.51          30.57        11.56
  Regulator of G-protein signaling 10                                                             36.15      0.000242661   RGS10         10.18       -1.31         19.60        5.87
  Selenoprotein M                                                                                 28.07      0.001559553   SELM          9.66        -1.34         16.17        5.54
  Serine/threonine-protein phosphatase 4 regulatory subunit 3A                                    76.44      2.27171E-08   SMEK1         3.15        -1.21         61.98        4.81
  Protein kish-A                                                                                  37.02      0.000198609   TMEM167A      12.5        1.28          8.05         8.95
  Transmembrane protein 205                                                                       34.49      0.000355631   TMEM205       8.99        -1.37         21.18        8.62
  Transmembrane protein 238                                                                       42.68      5.39511E-05   TMEM238       10.23       1.40          18.03        11.53
  Transmembrane protein 87A                                                                       55.86      2.59243E-06   TMEM87A       9.11        -1.33         56.74        5.69
  182 kDa tankyrase-1-binding protein                                                             106.18     2.40763E-11   TNKS1BP1      2.6         -1.46         181.69       4.86
  UDP-N-acetylhexosamine pyrophosphorylase-like protein 1                                         31.60      0.000691831   UAP1L1        1.38        -1.24         56.99        6.32
  zinc finger CCCH-type containing 18                                                             65.78      2.64005E-07   ZC3H18        5.42        -1.87         39.04        4.89
  Leucine-rich repeat-containing protein 59                                                       503.47     4.49936E-51   LRRC59        20.52       1.22          34.91        9.57
  rRNA 2\'-O-methyltransferase fibrillarin                                                        180.12     9.71673E-19   FBL           11.53       -1.33         33.76        10.18
  Clustered mitochondria protein homolog                                                          54.60      3.46545E-06   CLUH          2.14        1.20          146.58       6.13
  ATP-dependent RNA helicase DDX31                                                                282.98     5.03956E-29   DDX31         0.97        1.24          80.89        9.83
  Neurobeachin-like protein 2                                                                     23.89      0.004083194   NBEAL2        0.43        1.66          282.68       6.54
  NHP2 ribonucleoprotein                                                                          351.04     7.86182E-36   NHP2          33.33       -1.22         15.01        9.25
  WD repeat protein 55                                                                            59.96      1.00925E-06   WDR55         21.74       -1.43         12.54        6.74
  Nucleobindin-2                                                                                  526.89     2.04772E-53   NUCB2         27.86       1.24          50.16        5.12
  1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-1                                 49.48      1.12644E-05   PLCH1         0.8         1.38          114.43       7.64
  Ankyrin repeat domain-containing protein 5                                                      84.77      3.3358E-09    ANKEF1        1.42        1.33          86.61        8.28
  Calmodulin                                                                                      383.67     4.29621E-39   CALM          38.26       -1.40         16.83        4.22
  Calcyclin-binding protein                                                                       64.99      3.17122E-07   CACYBP        13.16       1.30          26.19        8.25
  calcium/calmodulin-dependent protein kinase kinase 2, beta                                      41.30      7.42096E-05   CAMKK2        6.41        -1.48         38.59        6.30
  Calmodulin-regulated spectrin-associated protein 3                                              25.23      0.002999163   CAMSAP3       0.48        1.56          134.67       8.35
  Calnexin                                                                                        1219.69    1.0747E-122   CANX          23.14       1.21          67.53        4.60
  Calcium-regulated heat stable protein 1                                                         181.64     6.85365E-19   CARHSP1       10.88       -1.46         15.88        8.21
  S-adenosylmethionine synthase isoform type-2                                                    22.48      0.00564937    MAT2A         3.98        1.62          19.46        9.10
  40S ribosomal protein S28                                                                       416.48     2.24773E-42   RPS28         30.43       1.65          7.84         10.70
  \*Tetraspanin                                                                                   48.28      1.48594E-05   TSPAN13       6.29        -2.11         17.75        6.29
  Desmoglein-2                                                                                    112.81     5.23745E-12   DSG2          7.6         1.23          122.22       5.24
  Integrin alpha-10                                                                               26.55      0.002213095   ITGA10        0.78        1.26          112.47       6.68
  Liprin-alpha-1                                                                                  36.20      0.000239776   PPFIA1        1.6         -1.26         133.89       6.25
  WD repeat-containing protein 61                                                                 46.62      2.17624E-05   WDR61         6.56        -1.20         33.56        5.47
  Syntaxin-12                                                                                     84.27      3.74231E-09   STX12         6.88        1.63          31.62        5.59
  \*Dihydropyrimidinase-related protein 5                                                         31.72      0.00067262    DPYSL5        3.68        1.67          20.85        6.42
  PDZ domain-containing protein GIPC1 isoform 2                                                   33.42      0.000454988   GIPC1         7.2         -1.30         26.06        5.57
  Crk-II of Adapter molecule crk                                                                  168.48     1.41897E-17   CRK           7.57        1.26          33.81        5.55
  Transducin-like enhancer protein 3                                                              30.90      0.000812831   TLE3          2.11        -1.45         82.17        7.20
  Platelet-activating factor acetylhydrolase IB subunit gamma                                     113.69     4.27563E-12   PAFAH1B3      21.65       1.34          25.72        6.84
  Histone H3.3                                                                                    828.78     1.32475E-83   H3F3A         44.85       1.29          15.32        11.27
  Histone H1.5                                                                                    536.77     2.10286E-54   HIST1H1B      21.24       2.49          22.57        10.92
  Histone H1.2                                                                                    1007.80    1.6588E-101   HIST1H1C      30.99       2.29          21.35        10.93
  Histone H1.4                                                                                    1069.83    1.0408E-107   HIST1H1E      30.59       2.89          21.85        11.03
  Histone H2B type 1-C/E/F/G/I                                                                    1342.18    6.0583E-135   HIST1H2BC     62.7        1.84          13.90        10.32
  Histone H3.1                                                                                    1117.98    1.5924E-112   HIST1H3A      44.85       1.54          15.39        11.12
  Histone H4                                                                                      1317.99    1.5896E-132   HIST1H4A      52.43       1.85          11.36        11.36
  Histone H2A type 2-C                                                                            969.32     1.16911E-97   HIST2H2AC     55.04       1.97          13.98        10.90
  Histone H2B type 2-E                                                                            1489.58    1.1021E-149   HIST2H2BE     62.7        1.86          13.91        10.32
  Histone H3.2                                                                                    1363.47    4.4975E-137   HIST2H3A      44.85       1.82          15.38        11.27
  Histone H2A.x                                                                                   516.44     2.27136E-52   H2AFX         59.44       1.22          15.14        10.74
  replication factor C subunit 5 isoform 4                                                        34.07      0.000391742   RFC5          2.67        2.24          38.14        7.80
  small ubiquitin-related modifier 2 isoform b precursor                                          154.56     3.50042E-16   SUMO2         16.9        -1.39         8.11         5.41
  deoxyuridine 5\'-triphosphate nucleotidohydrolase, mitochondrial isoform 3                      160.14     9.68456E-17   DUT           21.99       1.20          15.39        6.57
  Single-stranded DNA-binding protein, mitochondrial                                              882.96     5.06197E-89   SSBP1         53.38       1.22          17.25        9.60
  WD repeat-containing protein 72                                                                 21.02      0.007906786   WDR72         0.54        1.73          123.35       6.67
  Alpha-2-HS-glycoprotein                                                                         51.23      7.53356E-06   AHSG          4.9         2.19          27.34        6.52
  Stonin-2                                                                                        37.61      0.00017338    STON2         0.99        1.21          101.10       5.39
  protein arginine methyltransferase 1                                                            278.12     1.54264E-28   PRMT1         34.46       -1.37         37.68        6.15
  Proline-, glutamic acid- and leucine-rich protein 1                                             29.98      0.001004616   PELP1         2.02        2.20          110.02       4.30
  TBC1 domain family member 10B                                                                   32.11      0.000615177   TBC1D10B      0.87        -2.10         87.14        9.19
  Nuclear ubiquitous casein and cyclin-dependent kinases substrate                                204.85     3.27022E-21   NUCKS1        11.52       -1.23         27.28        5.08
  SLD5 homolog (SLD5), mRNA                                                                       72.76      5.29663E-08   GINS4         12.84       2.13          12.05        5.74
  Microsomal triglyceride transfer protein large subunit                                          39.58      0.000110154   MTTP          1.23        1.98          99.29        8.41
  Protein FAM87A                                                                                  23.60      0.004365158   FAM87A        4.9         -1.43         31.72        10.01
  39S ribosomal protein L2, mitochondrial                                                         47.97      1.5948E-05    MRPL2         2.62        1.22          33.28        11.30
  39S ribosomal protein L21, mitochondrial isoform a                                              51.24      7.51623E-06   MRPL21        15.83       -1.20         13.74        10.07
  Serpin B6                                                                                       108.58     1.38613E-11   SERPINB6      11.49       -1.21         46.34        5.76
  Vomeronasal type-1 receptor 5                                                                   23.95      0.00402717    VN1R5         1.96        -1.59         40.75        9.20
  cilia and flagella associated protein 58                                                        44.44      3.59536E-05   CFAP58        6.52        1.99          11.03        9.23
  Membrane-associated progesterone receptor component 1                                           156.79     2.09251E-16   PGRMC1        22.05       1.29          21.66        4.70
  FK506 binding protein12                                                                         205.15     3.05816E-21   FKBP1A        35.14       -1.37         3.96         5.78
  Peptidyl-prolyl cis-trans isomerase B                                                           548.34     1.4649E-55    PPIB          46.3        1.24          23.73        9.41
  selenide, water dikinase 1 isoform 3                                                            221.26     7.4799E-23    SEPHS1        16.2        1.24          35.46        5.21
  Probable Xaa-Pro aminopeptidase 3                                                               91.64      6.86257E-10   XPNPEP3       10.98       1.45          48.08        5.62
  mitochondrial ribosomal protein L38 (MRPL38)                                                    34.00      0.000398107   MRPL38        3.57        1.22          22.96        6.14
  39S ribosomal protein L4, mitochondrial                                                         52.08      6.19534E-06   MRPL4         15.21       -1.20         29.48        10.13
  MRPL43 protein (Fragment)                                                                       88.64      1.36673E-09   MRPL43        8.97        1.23          15.95        8.66
  60S ribosomal protein L32                                                                       68.10      1.54882E-07   RPL32         12.78       1.23          15.61        11.44
  proteasome assembly chaperone 4 isoform c                                                       50.67      8.57038E-06   PSMG4         24.04       -1.23         11.21        6.51
  N-terminal Xaa-Pro-Lys N-methyltransferase 1                                                    149.45     1.13471E-15   NTMT1         11.61       -1.99         25.46        5.52
  STE20/SPS1-related proline-alanine-rich protein kinase                                          800.51     8.88891E-81   STK39         13.35       -1.24         59.60        6.29
  toll interacting protein                                                                        62.64      5.44503E-07   TOLLIP        17.5        -1.27         8.65         8.35
  SUMO-conjugating enzyme UBC9                                                                    186.06     2.47947E-19   UBE2I         34.18       -1.27         18.00        8.66
  Putative NOL1/NOP2/Sun domain family member 5B                                                  53.31      4.66317E-06   NSUN5P1       7.14        -1.70         16.47        9.26
  THO complex subunit 2                                                                           40.48      8.95365E-05   THOC2         1.06        1.23          97.21        6.51
  ATP-dependent RNA helicase DHX29                                                                65.43      2.86418E-07   DHX29         0.73        1.28          155.14       8.09
  Neuron-specific calcium-binding protein hippocalcin                                             79.07      1.23796E-08   HPCA          6.22        1.63          22.41        4.97
  Olfactory receptor 5AC2                                                                         37.52      0.000177011   OR5AC2        2.27        -1.39         35.28        8.94
  A-kinase anchor protein 8                                                                       61.79      6.61769E-07   AKAP8         2.89        1.60          76.06        5.15
  Myeloid-associated differentiation marker                                                       61.52      7.04693E-07   MYADM         15.65       1.74          15.92        8.65
  \*NF-kappa-B-activating protein                                                                 26.49      0.002243882   NKAP          1.45        1.65          47.11        10.11
  \*ATP-binding cassette sub-family A member 5                                                    30.05      0.000988553   ABCA5         0.86        -5.84         104.30       7.12
  AP-1 complex subunit mu-2                                                                       47.21      1.90108E-05   AP1M2         4.02        -1.53         48.08        8.22
  AP-2 complex subunit mu-1                                                                       44.57      3.49424E-05   AP2M1         8.27        -1.20         42.67        9.39
  ADP-ribosylation factor 5                                                                       967.37     1.83259E-97   ARF5          56.11       1.23          20.52        6.79
  ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)            440.40     9.12033E-45   ARFGEF1       3.27        -1.23         142.44       6.13
  ARFAPTIN 1                                                                                      175.92     2.55929E-18   ARFIP1        17.14       1.25          28.40        7.72
  Cellular nucleic acid-binding protein                                                           117.58     1.74464E-12   CNBP          8.82        -1.62         18.73        7.71
  Metal transporter CNNM3                                                                         22.85      0.005188      CNNM3         0.91        1.22          70.59        7.12
  Protein CWC15 homolog                                                                           66.10      2.45471E-07   CWC15         4.8         -1.30         26.61        5.71
  Acyl-CoA-binding protein                                                                        504.05     3.93581E-51   DBI           50.57       -1.32         10.04        6.57
  Golgin subfamily A member 5                                                                     27.96      0.001599558   GOLGA5        9.4         1.32          12.84        6.04
  Hook homolog 1                                                                                  35.65      0.00027227    HOOK1         2.33        -1.28         79.97        5.19
  UPF0459 protein C19orf50                                                                        24.35      0.003672823   KXD1          5.11        -1.64         19.66        4.89
  LPS-responsive vesicle trafficking, beach and anchor containing                                 123.34     4.63532E-13   LRBA          1.75        -1.37         286.79       5.52
  28S ribosomal protein S16, mitochondrial                                                        56.67      2.15278E-06   MRPS16        9.49        1.38          15.34        9.50
  28S ribosomal protein S17, mitochondrial                                                        80.19      9.5737E-09    MRPS17        15.38       1.30          14.49        9.85
  28S ribosomal protein S18b, mitochondrial                                                       93.79      4.17548E-10   MRPS18B       7.91        1.50          24.34        8.56
  myosin, light chain 6, alkali, smooth muscle and non-muscle                                     497.53     1.76602E-50   MYL6          46.67       -1.25         15.01        5.00
  Myosin-Id                                                                                       149.00     1.25876E-15   MYO1D         2.49        -1.30         116.13       9.39
  Ran-binding protein 6                                                                           46.97      2.00815E-05   RANBP6        2.44        -1.25         124.63       5.01
  Ammonium transporter Rh type B                                                                  28.58      0.001386756   RHBG          11.34       1.28          10.57        8.76
  Secretory carrier-associated membrane protein 2                                                 135.77     2.64671E-14   SCAMP2        3.95        1.68          36.63        6.10
  Mitochondrial glutamate carrier 1                                                               84.11      3.8815E-09    SLC25A22      4.64        1.21          34.45        9.29
  ADP/ATP translocase 2                                                                           1271.34    7.3482E-128   SLC25A5       47.65       1.24          32.83        9.69
  spermatogenesis associated 7                                                                    29.05      0.001244515   SPATA7        16.67       -1.46         4.76         10.26
  Sarcalumenin                                                                                    23.75      0.004221453   SRL           2.32        -1.71         49.78        6.95
  Serine/threonine-protein kinase WNK1                                                            31.00      0.000794328   WNK1          0.71        2.19          206.52       7.15

Note: The asterisk (\*) indicates the proteins discussed in the manuscript.

Among the proteins that were differentially expressed, ER stress markers, such as 78 kDa glucose-regulated protein (GRP78) and protein disulfide isomerase A4 and A6 (PDIA4, PDIA6), as well as oxidative stress markers sulfiredoxin (SRXN1) and ubiquinone (NDUFS1 and NDUFS3) were up-regulated. Additional ER stress-related proteins identified among the up-regulations are eukaryotic translation initiation factor 2B (eIF2B) and eukaryotic translation initiation factor 4 binding protein (eIF4EBP1) with a respective significant fold change of 1.5 and 1.3 and the protein disulfide isomerase (PDI) A4 and A6 with a differential expression of 1.21 and 1.26, respectively. Key differentially expressed proteins induced by MSKE in C4-2 cells included those associated with apoptosis (e.g., STEAP2, PDCD6, MTDH, RAB5B, cytochrome c oxidase), autophagy (e.g., ACIN1, PI4KA, PGK2, MTDH), cytoskeleton and protein transport (e.g., cortactin, taxilin, radixin, filamin B), among others ([Table 1](#pone.0164115.t001){ref-type="table"}). Furthermore, C4-2 control cells had a higher percent of anti-apoptotic proteins compared to the MSKE-treated cells, suggesting that MSKE induces an ER stress/autophagy/apoptosis signature.

MSKE Induces Expression of ER Stress Mediated Pro-Apoptotic Response Proteins {#sec020}
-----------------------------------------------------------------------------

Western blot was used to measure the expression of proteins associated with ER stress response. Key ER stress response markers IRE-1 alpha and GRP78 ([Fig 2](#pone.0164115.g002){ref-type="fig"}) were up-regulated when compared to control cells. Apoptotic markers PARP, caspase-12 and DFF45 ([Fig 2](#pone.0164115.g002){ref-type="fig"}) were up-regulated in cells exposed to MSKE. These data suggest that MSKE may induce ER stress and UPR-mediated apoptosis.

![Quantitative Western blot of key ER stress markers.\
Western blot analysis in C4-2 cells treated with 20 μg/ml MSKE as compared to ethanol-treated controls. As a loading control total protein from Ponceau S staining was assessed. Expression of ER stress markers IRE1-alpha and GRP78 and pro-apoptotic markers DFF45, PARP and caspase-12 was analyzed and quantification of western blot analysis performed using Image J, NIH. The standard deviation was used to assess data dispersion.](pone.0164115.g002){#pone.0164115.g002}

MSKE Treatment Induces Autophagy {#sec021}
--------------------------------

Since MSKE induced expression of ER stress response proteins, we sought to determine if treatment with MSKE induces autophagy. We treated C4-2 cells with 5, 10 or 20 μg/ml MSKE for 72 h and stained with acridine orange. Treatment with higher concentrations of MSKE (10 and 20 μg/mL) showed extensive acridine orange leakage into the cytosol (orange staining), indicating that MSKE induces autophagy ([Fig 3A](#pone.0164115.g003){ref-type="fig"}). Since the 20 μg/mL MSKE treatment showed extensive acridine orange staining we decided to see if co-treatment with chloroquine, a known autophagy inhibitor would reverse the effects of MSKE on C4-2 cells. Co-treatment with 20 μg/mL MSKE and 20 μM chloroquine lead to a decrease in acridine orange staining compared to 20 μg/mL MSKE alone, indicating that MSKE may promote autophagy ([Fig 3B](#pone.0164115.g003){ref-type="fig"}). To further validate a role for MSKE in autophagy, we also performed immunofluorescence and western blot with the autophagic marker, LC3B. There was increased punctate staining for LC3B in MSKE plus chloroquine co-treatments, which indicates that chloroquine prevents fusion of autophagosomes to lysosomes, and thus causes an accumulation of autophagosomes ([Fig 3C](#pone.0164115.g003){ref-type="fig"}). Similarly, western blot analysis showed increased LC3BII expression in MSKE plus chloroquine treatments indicating that chloroquine had inhbitied MSKE-mediated autophagy and caused accumulation of LC3BII lipidation products ([Fig 3D](#pone.0164115.g003){ref-type="fig"}). Of note, we did not observe increased LC3BII with MSKE treatment alone ([Fig 3D](#pone.0164115.g003){ref-type="fig"}), possibly due to high autophagic flux that can sometimes not be detected unless one includes an autophagy inhibitor as previously reported \[[@pone.0164115.ref016]\].

![MSKE treatment induces autophagy.\
(A) C4-2 prostate cancer cells were treated with MSKE (0 μg/mL, 5 μg/mL, 10 μg/mL, and 20 μg/mL) for 72 h. Fixation was performed with methanol/ethanol 1:1 volume followed by washes with 1× PBS. The cells were then exposed to acridine orange (5 μg/ml) for 15 min at 37°C, followed by washes with 1× PBS, prior to counterstaining with DAPI. We observed that treatment with higher concentrations of MSKE (10 and 20μg/ml) showed extensive acridine orange leakage into the cytosol, producing a diffuse yellow color and an increase in lysosomes indicating that MSKE induces cell death via autophagy compared to control. (B) C4-2 cells were treated with MSKE, with and without 20 μM chloroquine, for 72 h. The cells were then exposed to acridine orange (5 μg/ml) for 15 min at at 37°C, followed by washes with 1× PBS, prior to counterstaining with DAPI. Chloroquine treatment reversed the effects of MSKE. (C) Immunofluorescence staining for LC3B was performed on C4-2 cells treated with MSKE plus or minus chloroquine for 72 h. (D) Western blot analysis for LC3B was performed on C4-2 cells treated with MSKE plus/minus chloroquine. Image J analysis was performed to plot the ratios of LC3BI and LC3BII relative to actin loading control. The results are representative of experiments that have been performed in triplicate at least two times independently. Graphical data represents three independent experiments; \* means 0.05 \> *p* value \> 0.01, \*\* means 0.01 \> *p* value \> 0.001.](pone.0164115.g003){#pone.0164115.g003}

MSKE Promotes Autophagy-Mediated Apoptosis {#sec022}
------------------------------------------

To confirm that MSKE causes apoptosis, we treated the C4-2 cells with 5, 10, or 20 μg/ml MSKE and performed a TUNEL assay. Increased TUNEL staining (green) was observed with higher doses of MSKE ([Fig 4A](#pone.0164115.g004){ref-type="fig"}). These findings correlate with the Western blot analysis where up-regulation of pro-apoptotic markers PARP and caspase-12 was observed ([Fig 2](#pone.0164115.g002){ref-type="fig"}). These results support the hypothesis that MSKE induces apoptosis in C4-2 prostate cancer cells. To support the findings in the TUNEL assay and show that there was a correlation between autophagy and apoptosis, we performed quantitative apoptosis assay using flow cytometry *via* the Alexa Fluor 488 Annexin V in the presence or absence of chloroquine (autophagy inhibitor). Graphical representation of the apoptosis assay showed that treatment with MSKE led to an increase of apoptosis which was abrogated by treatment with chloroquine ([Fig 4B](#pone.0164115.g004){ref-type="fig"}). Western blot analysis confirmed these findings by showing that MSKE-mediated increase in pro-apoptotic proteins BAX, cleaved caspase-3 and -7, and decrease in anti-apoptotic protein BCL2 was abrogated by co-treatment with chloroquine ([Fig 4C and 4D](#pone.0164115.g004){ref-type="fig"}). Therefore, MSKE-mediated autophagy leads to apoptosis.

![MSKE induces autophagy-mediated apoptosis.\
(A) C4-2 prostate cancer cells were treated with increasing concentrations of 0μ g/mL, 5 μg/mL, 10 μg/mL, and 20 μg/mL for 72 h. The cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% sodium citrate and 0.1% Triton X. DNA fragmentation was determined by TdT-mediated dUTP nick end labeling (TUNEL). TUNEL assay (green channel). DAPI (blue channel) is used to locate the nuclei of the cells. (B) Cells were stained with Annexin V- Alexa Fluor 488 and PI and analyzed by flow cytometry following treatment with 5 μg/mL MSKE with or without 20 μM chloroquine. Percent of cells in the lower right quadrant that represent Annexin V ^+^/PI^-^ or early apoptotis and cells in the upper right quadrant that represent Annexin V ^+^/PI^+^ or late apoptotis was graphed. (C) Western blot analysis was performed to examine pro-apoptotic markers (Bax, cleaved caspase-3 and -7) and anti-apoptotic marker (BCL2) following treatment with MSKE in the presence or absence of 20 μM chloroquine. Actin was utilized as a loading control. (D) Results of western blot were analyzed using Image J and graphed. The experiments were performed in triplicate at least two times independently. Graphical data represents three independent experiments; \* means 0.05 \> *p* value \> 0.01, \*\* means 0.01 \> *p* value \> 0.001, and \*\*\* means *p* value \< 0.001.](pone.0164115.g004){#pone.0164115.g004}

Discussion {#sec023}
==========

We investigated the impact of MSKE on the C4-2 proteome using a quantitative TMT isobaric labeling approach with subsequent protein identification by mass spectrometry. Changes in C4-2 cells were also examined by Western blot. Autophagy and apoptosis were determined by acridine orange, TUNEL/Annexin V analyses, respectively. The results indicated that MSKE significantly regulated components of the UPR stress inducing pathways that include chaperones, ER stress antioxidant enzymes, proteolytic enzymes, cytoskeletal proteins, as well as enzymes involved in autophagy or apoptosis. Autophagy is a dynamic process, whereby cytoplasmic proteins and cellular organelles are enveloped in autophagosomes and degraded by fusion with lysosomes for amino acid and energy recycling \[[@pone.0164115.ref017]\]. There is evidence that autophagy can play a critical role in cellular survival \[[@pone.0164115.ref018]\] but, it is frequently activated in tumor cells following anticancer therapies such as drug treatment and gamma-irradiation \[[@pone.0164115.ref019]\]. Apoptosis is defined as an active, fixed-pathway process of cell death characterized by cell shrinking, cytoplasmic condensation, ladder DNA degradation, and nuclear fragmentation resulting in the formation of apoptotic bodies. Initial studies on the mechanism of action of MSKE, suggest the ability to induce apoptosis via activation of the caspase cascade. The increase of apoptosis after MSKE treatment was confirmed with the TUNEL and Annexin V assays, in agreement with previous studies that have shown that MSKE promotes apoptosis in prostate cancer cells \[[@pone.0164115.ref007]\].

Our current study identified several proteins associated with apoptosis triggered by MSKE treatment such as STEAP2, PDCD6, MTDH, RAB5B, and cytochrome C oxidase ([Table 1](#pone.0164115.t001){ref-type="table"}). STEAP2, also known as 6-transmembrane protein of the prostate 1 (STAMP1) is overexpressed in several types of human cancers, namely prostate, bladder, colon, pancreas, ovary, testis, breast, and cervix, but its clinical significance and role in cancer cells is still unclear \[[@pone.0164115.ref020]\]. STEAP2 participates in a wide range of biological processes, including molecular trafficking in the endocytic and exocytic pathways. It also controls cell proliferation and apoptosis. STEAP2 was down-regulated in C4-2 cells. It has been shown that STEAP2 blockage has a pro-apoptotic role that causes mitochondrial damage, and decreases cell proliferation and glucose uptake \[[@pone.0164115.ref020]\]. MTDH was up-regulated by 1.91 fold upon MSKE treatment in C4-2 cells. MTDH has been proposed to promote tumor progression through the integration of multiple signaling pathways including ras, myc, Wnt, PI3K/AKT, and NF-κB in various types of cancer \[[@pone.0164115.ref021]--[@pone.0164115.ref024]\].

The nuclear protein Apoptotic Chromatin Condensation Inducer 1 (ACIN1) is known to function in DNA fragmentation and is activated during apoptosis by caspase-3. It also plays an active role in spliceosome assembly because it is a critical subunit of an apoptosis and splicing-associated protein (ASAP) complex \[[@pone.0164115.ref025],[@pone.0164115.ref026]\]. ACIN1 was down-regulated in our study by -1.60 fold and we speculate that MSKE induced an anti-apoptotic/survival response in C4-2 cells by down-regulating ACIN1. Taxilin protein (TXLNA), a binding partner of the syntaxin family that functions as a central player in the intracellular vesicle traffic, and is a marker of testicular injury \[[@pone.0164115.ref027]\] was also upregulated upon MSKE treatment.

Several results support the induction of apoptosis by MSKE via autophagy. The acridine orange staining showed that induced autophagy increased with MSKE treatment in a dose-dependent manner. Additionally, ER stress was significantly induced upon MSKE treatment in C4-2 cells as seen in the up-regulation of several stress-related proteins (e.g., GRP78, PDIA4, PDIA6, eIF2B, eIF4EBP1). We also identified COL4A3BP whose down-regulation sensitizes cancer cells to multiple cytotoxic agents, potentiating ER stress \[[@pone.0164115.ref028]\]. Lysosomal inhibitors such as chloroquine that inhibit acidification inside the lysosome or inhibit autophagosome-lysosome fusion and can block the degradation of LC3BII, leading to the accumulation of LC3BII, are good indicators for autophagy \[[@pone.0164115.ref029]\]. Co-treatment with MSKE plus chloroquine in C4-2 cells increased LC3B punctate staining as shown by immunofluorescence, and increased LC3-BII expression as shown by western blot analysis, proving that MSKE promotes autophagy which is blocked by chloroquine leading to accumulation of LC3BII. We speculated, however, that at 72 h we failed to see increased LC3BII with MSKE treatment alone due to high autophagic flux. This problem that sometimes arises when LC3BII expression does not increase when assayed at a certain time point as expected due to high autophagic flux is discussed in great detail with the conclusion that it is better to gauge autophagy by examining autophagosome accumulation in the presence of chloroquine \[[@pone.0164115.ref016]\]. We also demonstrated that chloroquine was able to reverse the extensive acridine orange leakage into the cytosol.

Degradation of cytosolic proteins in lysosomes is a hallmark of autophagy \[[@pone.0164115.ref030]\]. The absence of chromatin condensation is another characteristic of autophagy and indicative of apoptosis \[[@pone.0164115.ref031]\]. Recent studies have shown that a variety of anticancer therapies (including those that stimulate ER stress) activate autophagy in tumor cells, which has been proposed to either enhance cancer cell death or act as a mechanism of resistance to chemotherapy \[[@pone.0164115.ref032]\]. Autophagy works as a tumor suppression mechanism by removing damaged organelles/proteins, limiting cell growth and minimizing genomic instability \[[@pone.0164115.ref033]\]. Phosphatidylinositol 4-Kinase (PI4KA), a protein involved in both nonselective and selective types of autophagy \[[@pone.0164115.ref034]\], was up-regulated in MSKE-treated C4-2 cells. The expression of metadherin (MTDH), also known as astrocyte-elevated gene-1, a protein that may protect normal cells from serum starvation-induced death through protective autophagy \[[@pone.0164115.ref035]\], increased 1.91 fold in the presence of MSKE. In addition, phosphoglycerate kinase (PGK2), a cytosolic and glycolytic marker, was down-regulated by MSKE in C4-2 cells, suggesting that it may have been taken up into autophagic bodies \[[@pone.0164115.ref036]\].

ER stress was evident by the up-regulation of key ER stress markers like GRP78 and PDIA4, A6. Proper protein folding, maturation, and stabilization of the nascent protein in the ER requires a highly oxidizing ER environment, which is essential for the diverse post-translational and co-translational modifications (e.g., glycosylation, disulfide bridge formation) to which proteins are subjected after entering the ER. These processes are assisted and monitored by several resident chaperones and binding proteins, including glucose-regulated proteins like GRP78, which was up-regulated in the presence of MSKE. Folding enzymes, such as the thioredoxin-like protein (PDI), oxidize cysteine residues in nascent proteins (i.e., oxidative folding) resulting in the formation of intra- and intermolecular disulfide bonds. MSKE resulted in ER stress pathway activation and subsequent translation initiation component activation (i.e., eIF4EPB, eIF2). Moreover, the upregulation of pro-apoptotic markers MTDH, caspase 12, Cytochrome C oxidase, PDCD6 and NQO1, along with the increased apoptosis visualized by TUNEL and Annexin V staining, suggest that the ER stress response might eventually trigger apoptosis.

Overexpression of MTDH, also known as LYRIC, is observed in a variety of cancers and is involved in cancer initiation, proliferation, invasion, metastasis and chemoresistance \[[@pone.0164115.ref037]\]. MTDH also activates the PI3K/Akt pro-apoptotic pathway in cancer \[[@pone.0164115.ref038]\] and its inhibition induces apoptosis in prostate cancer cells \[[@pone.0164115.ref039]\]. Hudson et al. have also shown that treatment with MSKE activates the PI3K/Akt pro-apoptotic pathway in prostate cancer cells \[[@pone.0164115.ref007]\].

The upregulation of cytoplasmic C oxidase and Glyoxalase I (GLO1) suggests that MSKE also interferes with glycolysis and mitochondrial metabolism in C4-2 cells. GLO1 is a ubiquitous cellular defense enzyme involved in detoxification. GLO1 expression may protect cells against methylglyoxal-dependent protein adduction and cellular damage associated with diabetes, cancer, and chronological aging. GLO1 upregulation has been shown to play a pivotal role in glycolytic adaptations of cancer cells \[[@pone.0164115.ref040]\]. Phosphoglycerate kinase, a protein encoded by the *PGK1* and *PGK2* genes, is a glycolytic protein activated by MSKE. Phosphoglycerate kinase converts 1,3-diphosphoglycerate into 3-phosphoglycerate in the glycolysis pathway. *PGK1* is located on the X chromosome and is ubiquitously expressed whereas *PGK2*, whose differential expression was induced by MSKE in C4-2 cells, is a retrotransposed copy of *PGK1* located on chromosome 6 that shows a testis specific expression pattern \[[@pone.0164115.ref041],[@pone.0164115.ref042]\]. Our analyses demonstrated overexpression of HYOU1, CTTN and DPYSL5, and down-regulation of ABCA5 proteins in C4-2 cells. These proteins have been implicated in other cancer cells and tumor types and are involved in relevant cell mechanisms for apoptosis evasion, increased tumor invasiveness, tumor hypoxia, cellular respiration, and mitochondrial fragmentation. ABCA5 is a member of the ATP-binding cassette transporter 1 subfamily of genes whose mutations are linked to several human genetic disorders including cystic fibrosis, neurological disease, retinal degeneration, cholesterol and bile transport defects, anemia, and drug response phenotypes \[[@pone.0164115.ref043]\].

MSKE also activates oxidative stress and ROS pathways through aldehyde dehydrogenases (ALD), sideroflexin, sulfiredoxin and DHRS1. ALDH belongs to a group of NAD(P)^+^-dependent enzymes involved in oxidation of a large number of aldehydes into their weak carboxylic acids \[[@pone.0164115.ref044]\]. ALDH is important for drug resistance, cell proliferation, differentiation, and response to oxidative stress in prostate cancer and its activity is used to distinguish between normal cells and their malignant counterparts. In a previous study, high ALDH activity was used to isolate human prostate cancer cells with significantly enhanced clonogenic and migratory properties both *in vitro* and *in vivo*. As seen in other cancer tissues, the percentage of ALDH cells in prostate cancer cell lines are also related to tumorigenicity and metastatic behavior \[[@pone.0164115.ref045]\].

MSKE induced apoptosis via the up-regulation of ER stress-driven caspase-3,-7 and -12. Treatment with chloroquine blocked the effects of MSKE on apoptosis by up-regulating BCL-2, decreasing BAX, preventing the cleavage of caspase-3 and -7 and antagonizing MSKE-mediated increase in early and late apoptosis. This further supports the findings that MSKE-mediated autophagy leads to apoptosis. MSKE also prompted the down-regulation of anti-apoptotic and survival proteins like Annexin A4 (ANXA4), a member of the Ca^2+^-regulated and phospholipid-binding annexin superfamily. ANXA4 expression is increased in many cancer types, including cancers of renal, gastric, colonic, ovarian, and cervical origins \[[@pone.0164115.ref046]--[@pone.0164115.ref050]\]. Its expression has been linked to loss of cell-to-cell adhesion, increased metastasis, and chemo-resistance, and it is considered a potential cancer diagnostic and therapeutic target \[[@pone.0164115.ref051],[@pone.0164115.ref052]\]. *In vitro* studies suggest that ANXA4 exhibits an anti-apoptotic effect by activating NF-κB transcriptional activity \[[@pone.0164115.ref053],[@pone.0164115.ref054]\]. Our data suggests that MSKE may induce apoptosis by decreasing ANXA4, and increasing MTDH.

Recently, the cross-talk between autophagy and apoptosis has been considered as a key factor in the development and treatment of cancer \[[@pone.0164115.ref055]\]. The two pathways share molecular regulators and, in some cases, are activated by the same stimulus. Taken together, the results of this study suggest that MSKE induces apoptosis through signaling pathways that modulate ER stress, autophagy, cytoskeletal changes, cell-matrix, and cell-cell adhesion, as well as glycolysis and mitochondrial metabolism ([Fig 5](#pone.0164115.g005){ref-type="fig"}); opening the door to novel therapeutic and clinical exploitations.

![Proposed model highlighting unfolded protein response pathway with pro-apoptotic protein signatures triggered by ER stress in MSKE treated C4-2 prostate cancer cells.\
MSKE treatment of C4-2 cells promoted an unfolded protein response (UPR) pathway in a mitochondria-specific stress response (UPRmt) with pro- and anti-apoptotic protein signature triggered by ER stress. Strong ER stress and activation of the UPR initiate apoptosis. In contrast, mild UPR activation induces a beneficial ER homeotic response by reducing the load of misfolded proteins and by activating cellular protective mechanisms like autophagy. PERK mediates phosphorylation of eIF2α and ATF4-dependent transcriptional activation of autophagy proteins. The model highlights insufficient folding or degradation capacity in the mitochondria, contributing to apoptosis.](pone.0164115.g005){#pone.0164115.g005}

Supporting Information {#sec024}
======================

###### Differentially expressed proteins in MSKE-treated and control cultures.

Detailed information including protein ID, gene name, number of amino acids, molecular weight, calculated pI, description, coverage samples, protein expression, change folds, and p-values.

(XLSX)

###### 

Click here for additional data file.

C4-2 human prostate cancer cells were a gift from Dr. Leland Chung (Cedars Sinai Medical Center, Los Angeles, CA). Dr. Tamaro Hudson (Howard University, Washington, DC) kindly provided the MSKE. The authors thank Dr. Lycely del C. Sepúlveda-Torres for editorial assistance.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: **Conceptualization:** VOM.**Formal analysis:** QZ NB GW.**Funding acquisition:** VOM NB GW.**Investigation:** LJB MR OH QZ.**Methodology:** VOM JZ GW TH.**Supervision:** VOM NB LC.**Visualization:** LJB MR VOM NB.**Writing -- original draft:** VOM NB LJB MR.**Writing -- review & editing:** TH LC.

[^3]: ‡ These authors are joint senior authors on this work.
